rfhg_139665.1

Basic information about the TSS

---

TSS ID: rfhg_139665.1 Species: human Chr: chr11		Start: 65919773 End: 65919805 Strand: +
Source datasets	DRA013844|PRJNA4843412
Protocol	CAGE|NETCAGE
TSS cluster detected*	2

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D2460377,EH38E1545726)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: U41843:0 GeneID: 10589 HGNC/MGI_ID: HGNC:3019 UniProt_ID: Nearer transcript ids and distances: ENST00000532933.1:-49 ENST00000527119.5:-271 AB463581:-271 EU446936:-271 CU679579:-271 X96506:-271 BC010025:-324 ENST00000530791.5:325 ENST00000531121.5:-336 ENST00000312515.7:-347 NM_006442.4:-347 ENST00000376991.6:-438 ENST00000525501.5:-499 view more...

Gene_name: DR1 associated protein 1 Gene_symbol: DRAP1 Gene_synonyms: NC2-alpha Gene_source: HGNC:3019

TATA-Box annotation

---

Distance to TSS:	363
Nearest PromoterID:	NM_006442
Entrez ID:	10589
Nearest Unigene:	Hs.356742
Nearest Refseq:	NM_006442
Nearest Ensembl:	ENSG00000175550
Gene Name:	DR1 associated protein 1
Gene Alias:	NC2-alpha
Gene Type:	protein-coding
CpG%:	0.093750
GC%:	0.606061
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@DRAP1 p2@DRAP1 p3@DRAP1 p4@DRAP1 p5@DRAP1 p6@DRAP1 p7@DRAP1 p8@DRAP1 p9@DRAP1 p10@DRAP1
Sample		p1@DRAP1	p2@DRAP1	p3@DRAP1	p4@DRAP1	p5@DRAP1	p6@DRAP1	p7@DRAP1	p8@DRAP1	p9@DRAP1	p10@DRAP1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	23.96	4.09	1.75	0.58	12.47	0.97	0.39	0.58	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	26.30	3.64	0.40	0.40	13.15	1.42	0.00	0.00	0.81	0.40
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	28.94	2.70	2.31	0.58	11.96	1.16	0.19	0.00	0.39	0.96
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	23.08	3.33	2.29	0.21	9.15	0.42	0.21	0.21	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	23.85	5.40	1.12	0.67	12.82	1.12	0.00	0.45	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	24.23	4.26	1.55	0.58	13.57	1.94	0.00	0.19	0.19	0.78
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	34.43	3.49	3.92	0.65	26.58	0.65	0.22	0.65	0.22	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	30.04	3.63	2.66	0.24	21.56	0.97	0.48	0.24	0.24	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	28.42	2.99	2.56	0.64	16.24	0.64	0.00	0.21	0.00	1.07
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	16.81	1.16	2.32	0.00	29.56	1.16	0.58	0.58	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	14.55	1.62	2.43	0.81	31.53	0.40	0.00	0.00	0.00	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	20.73	2.03	1.63	1.63	28.05	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	34.17	1.45	3.87	6.13	2.90	1.61	1.13	0.32	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	30.52	1.80	5.71	5.41	3.61	0.75	0.75	0.30	0.00	0.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	37.10	2.42	2.63	4.39	3.29	0.66	0.88	0.66	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	23.39	1.26	2.77	4.78	2.26	0.75	0.25	1.51	0.25	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	23.15	1.53	5.24	6.33	2.18	0.00	0.00	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	28.26	0.42	2.95	6.75	1.69	1.27	0.00	0.84	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	27.19	1.60	5.86	4.27	3.20	0.53	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	35.05	2.56	4.21	5.27	3.46	0.75	1.65	0.30	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	37.16	1.87	5.88	5.75	2.14	0.67	1.20	0.27	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	39.36	4.83	4.83	6.39	4.14	2.07	0.52	1.21	0.35	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	31.67	3.23	5.17	6.85	4.14	0.78	1.16	0.78	0.13	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	31.06	1.70	5.10	8.25	1.70	0.49	0.73	1.94	0.00	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	31.99	3.35	3.87	9.29	3.10	3.10	1.03	2.58	0.00	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	35.77	1.90	6.96	5.38	3.17	2.22	1.58	1.27	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	26.92	2.20	6.59	9.89	3.30	1.10	1.10	3.30	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	47.86	8.96	6.13	11.08	5.66	2.12	2.83	1.41	0.94	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	38.28	5.49	4.68	7.27	2.91	3.55	2.58	2.91	0.32	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	45.60	5.07	6.51	8.87	6.15	2.90	1.81	3.08	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	41.87	5.02	9.42	6.70	3.35	1.26	1.88	0.84	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	37.51	3.13	6.06	6.45	3.91	1.56	1.76	2.15	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	35.87	2.95	4.64	5.28	3.38	3.38	1.90	2.53	0.42	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	38.27	4.95	9.24	6.43	5.28	2.14	1.65	1.48	0.49	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	44.32	5.05	6.36	9.54	4.49	2.43	1.87	2.99	0.19	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	41.97	4.22	5.94	7.66	4.41	1.92	2.30	2.30	0.57	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	40.06	5.52	7.36	7.36	4.29	2.45	1.43	2.25	0.41	1.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	40.50	3.83	6.65	8.46	3.02	2.01	1.81	2.62	0.81	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	34.84	5.13	7.83	7.83	8.64	1.89	2.97	2.43	0.27	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	37.45	4.08	5.52	7.68	5.04	3.84	1.20	0.96	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	36.70	7.76	5.41	6.35	4.23	3.76	2.12	3.53	0.24	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	39.38	5.42	4.68	7.47	5.12	2.93	3.07	2.78	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	38.59	4.01	4.85	6.96	1.69	2.95	1.48	2.53	0.00	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	39.34	4.20	4.90	7.17	3.67	2.10	1.92	1.05	0.87	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	48.19	5.42	4.42	6.83	4.62	3.21	1.81	2.61	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	43.74	6.05	7.68	9.54	5.35	3.72	1.63	2.56	0.47	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	36.47	3.36	6.00	8.64	3.60	1.44	2.40	1.68	0.24	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	44.11	6.26	7.15	5.96	4.77	2.68	1.79	2.38	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	42.61	4.07	5.03	7.66	5.51	3.35	1.68	2.15	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	45.70	5.86	4.45	5.86	5.86	2.22	2.22	2.02	0.40	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	46.73	4.71	3.89	5.12	3.69	2.25	2.87	2.66	0.41	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	43.14	3.56	6.23	7.34	2.89	2.00	1.78	1.33	0.22	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	195.89	0.00	13.99	41.98	27.98	27.98	0.00	13.99	0.00	69.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	28.39	2.48	2.84	5.68	1.77	1.77	1.77	1.42	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	31.48	2.65	3.65	5.30	3.98	1.99	2.32	1.66	0.33	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	28.52	7.55	11.75	10.07	9.23	0.84	2.52	3.36	0.84	6.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	48.68	5.97	5.51	5.97	2.76	2.76	3.21	0.46	0.46	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	23.66	2.27	6.16	2.92	2.27	2.59	1.30	1.94	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	29.23	3.21	2.89	4.18	5.14	2.25	1.93	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	45.89	5.03	4.09	5.34	5.97	1.26	0.63	1.57	1.26	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	34.55	0.71	2.12	5.64	0.00	0.71	1.41	0.71	0.00	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	29.72	3.36	6.73	6.17	1.68	1.68	0.56	1.12	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	54.14	4.78	3.98	5.57	7.96	1.59	0.80	3.18	0.00	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	49.27	2.04	1.70	6.80	5.10	2.72	1.36	2.04	0.68	1.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	21.12	0.65	3.25	2.60	0.65	1.30	0.65	1.95	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	30.88	1.77	4.26	3.90	0.71	1.06	1.06	1.06	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	32.33	0.00	0.00	16.16	16.16	0.00	16.16	0.00	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	7.90	7.90	55.28	15.79	0.00	7.90	0.00	0.00	39.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	56.06	2.93	5.36	5.36	1.95	0.00	1.46	2.44	0.98	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	42.64	1.49	3.97	3.97	4.46	1.98	2.48	1.49	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	48.32	6.10	4.22	3.75	1.88	0.94	2.81	1.41	0.00	1.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	68.89	2.98	3.64	7.62	2.32	0.66	0.66	0.99	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	48.88	1.86	3.71	6.19	2.17	0.31	0.62	0.31	0.00	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	55.95	3.06	6.42	5.50	3.06	0.92	0.92	0.61	0.00	0.92
Adipocyte - breast, donor1	11376-118A8	58.76	4.59	5.07	2.53	3.33	1.43	0.32	0.16	0.32	0.32
Adipocyte - breast, donor2	11327-117E4	71.87	7.06	3.21	3.85	2.89	2.89	0.48	0.48	0.32	1.44
Adipocyte - omental, donor1	11473-119C6	48.35	3.69	3.31	1.91	2.80	1.15	0.13	0.13	0.13	0.51
Adipocyte - omental, donor2	11474-119C7	82.22	8.97	6.73	2.24	2.24	2.99	1.49	0.00	0.00	2.99
Adipocyte - omental, donor3	11475-119C8	58.95	2.68	1.34	2.68	3.35	0.33	0.67	0.00	0.00	0.67
Adipocyte - perirenal, donor1	11476-119C9	61.25	0.64	2.55	1.91	1.28	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	52.78	7.70	3.30	2.20	3.30	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	113.81	39.74	28.90	12.65	6.77	11.74	2.26	4.97	1.81	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	68.12	3.30	3.65	4.34	2.43	0.87	0.00	0.35	0.17	0.35
Adipocyte differentiation, day04, donor1	13019-139D4	62.00	1.96	2.35	2.54	1.76	0.39	0.00	0.20	0.00	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	36.03	1.29	1.03	3.35	0.77	0.26	0.00	0.51	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	49.62	5.30	1.67	2.79	1.67	1.12	0.28	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	47.61	1.76	1.76	2.94	2.35	0.59	0.00	0.59	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	78.26	4.83	3.94	2.98	1.85	0.97	0.24	0.40	0.48	0.72
Adipocyte differentiation, day08, donor2	13023-139D8	52.29	1.61	3.55	2.90	1.94	0.32	0.00	0.32	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	30.92	2.67	1.07	2.67	2.67	0.00	1.07	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	33.94	3.90	1.67	1.11	2.23	1.11	0.00	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	61.97	3.74	1.66	1.66	1.66	0.00	0.00	0.42	0.00	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	49.23	1.76	1.26	1.00	1.51	0.75	0.75	0.25	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	36.65	3.93	1.31	0.98	2.62	0.98	0.33	0.33	0.00	0.98
Adipocyte differentiation, day12, donor4	13030-139E6	38.06	3.35	3.04	1.52	0.61	1.22	0.61	0.30	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	138.12	22.76	6.41	6.63	14.14	7.51	1.99	0.22	1.55	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	191.12	24.38	6.45	11.12	18.29	7.89	3.23	0.72	1.08	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	105.43	7.19	8.39	9.58	3.59	1.20	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	70.34	1.08	1.62	0.72	3.96	0.54	0.18	0.00	0.18	0.36
Amniotic Epithelial Cells, donor2	11613-122A2	82.00	0.00	1.67	0.00	5.02	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	81.36	1.64	2.05	2.47	3.08	0.41	0.21	0.00	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	92.57	3.89	21.86	20.48	6.29	1.49	2.17	1.72	0.34	0.11
Anulus Pulposus Cell, donor2	11463-119B5	85.47	5.14	22.78	26.45	4.41	2.20	1.71	0.24	0.24	0.24
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	65.15	7.19	13.03	11.23	3.15	5.39	1.80	1.35	0.45	0.90
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	78.15	8.68	14.76	14.76	3.47	4.34	1.30	2.17	2.17	0.87
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	47.09	4.28	8.56	12.84	2.14	6.42	4.28	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	75.03	10.46	9.27	13.45	4.48	3.89	2.39	0.90	0.90	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	92.32	15.18	18.97	10.12	6.32	10.12	2.53	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	52.81	5.28	15.18	8.58	6.60	5.94	2.64	0.66	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	68.23	9.75	14.29	13.00	8.45	5.20	2.27	1.30	0.97	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	74.27	13.59	14.08	13.59	5.34	10.19	1.94	1.46	0.00	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	56.42	6.53	19.60	7.72	4.16	3.56	1.19	1.78	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	73.82	12.05	10.92	12.05	3.77	7.91	3.39	1.13	0.00	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	81.28	7.98	9.43	15.24	9.43	6.53	1.45	2.18	0.73	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	50.15	3.76	7.52	7.52	2.51	3.76	1.25	5.02	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	68.37	7.91	12.68	9.39	4.45	3.46	1.98	0.49	0.99	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	79.16	10.92	17.74	10.92	9.55	9.55	0.00	1.36	1.36	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	38.75	4.98	9.50	5.88	4.07	4.67	1.96	1.06	0.60	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	78.76	7.50	13.93	11.79	8.04	4.29	2.68	2.14	0.54	0.54
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	88.04	11.34	16.44	11.90	6.05	4.16	2.46	0.76	0.76	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	52.12	6.41	13.36	11.23	5.88	6.41	2.41	1.34	0.53	1.07
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	61.45	13.66	10.73	9.75	3.90	4.88	4.88	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	86.74	8.46	12.94	12.94	5.47	4.48	3.32	1.82	1.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	30.02	4.80	24.01	6.00	6.00	4.80	0.00	6.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	99.12	7.08	17.70	14.16	17.70	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	90.57	11.32	13.21	12.52	5.32	6.18	2.06	1.37	0.69	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	54.53	0.00	16.78	12.58	8.39	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	67.47	10.19	7.28	14.08	4.85	4.85	2.43	1.94	0.97	0.97
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	105.11	9.87	14.80	16.70	3.04	5.31	1.52	1.90	1.14	0.76
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	54.51	3.63	18.17	12.11	3.63	3.63	0.00	2.42	3.63	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	71.25	7.41	14.25	10.26	4.56	3.42	2.85	2.85	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	76.32	10.05	11.76	14.11	4.06	4.70	1.50	1.28	0.64	0.43
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	56.78	4.13	13.68	11.10	3.36	5.16	2.84	1.81	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	82.58	10.32	14.55	11.26	8.45	6.10	0.94	1.88	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	86.82	9.97	11.25	12.54	4.50	4.50	1.29	0.96	1.29	1.61
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	59.93	4.28	12.84	8.56	6.42	7.85	1.43	0.71	1.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	73.70	9.94	15.79	15.21	7.60	5.26	0.58	2.34	1.17	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	75.57	9.33	10.54	9.33	6.02	3.61	1.81	0.90	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	60.59	0.00	13.07	15.44	2.38	10.69	1.19	0.00	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	91.54	13.73	14.24	16.78	6.61	3.56	3.56	3.05	0.00	1.02
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	100.09	8.66	12.99	12.23	2.80	6.62	1.53	1.53	1.27	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	52.10	5.72	9.53	13.34	6.99	2.54	1.91	1.91	1.27	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	70.77	9.93	14.67	13.38	4.75	6.47	2.16	0.86	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	79.17	7.62	10.16	9.74	4.45	6.56	2.12	1.69	0.00	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	52.49	4.93	12.47	7.83	3.77	4.06	0.87	1.16	0.00	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	72.74	6.61	10.39	19.84	5.67	2.83	3.78	0.00	0.00	1.89
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	88.66	7.29	11.19	13.05	3.73	4.75	1.19	0.68	0.51	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	69.49	6.95	11.58	9.27	2.32	4.63	0.00	0.00	2.32	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	69.71	6.34	10.56	14.79	12.68	6.34	0.00	2.11	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	81.91	10.94	12.65	11.79	5.57	5.36	2.36	1.07	1.07	0.64
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	40.91	4.81	13.24	9.02	6.02	6.02	3.61	1.20	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	69.25	8.75	18.22	14.58	5.10	5.83	5.10	4.37	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	100.23	9.88	11.03	12.41	5.52	7.59	2.07	1.15	1.38	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	40.80	10.20	17.85	2.55	0.00	2.55	2.55	5.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	34.83	9.15	10.93	5.59	3.31	8.39	1.53	0.76	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	87.74	11.97	13.42	15.48	5.57	6.61	2.48	1.03	0.21	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	49.57	10.10	10.40	9.49	3.67	4.90	1.22	0.31	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	84.61	9.56	10.04	9.08	3.82	2.39	2.39	1.91	1.43	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	75.39	7.32	9.76	8.87	3.77	5.32	0.67	2.00	0.89	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	41.20	7.63	15.26	9.15	4.58	1.53	3.05	1.53	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	74.77	15.51	18.83	13.29	5.54	7.75	1.66	1.11	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	73.08	7.68	7.41	12.97	3.44	6.09	2.38	1.06	0.53	0.79
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	63.97	3.27	13.81	10.90	2.54	5.82	2.91	1.45	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	167.28	10.07	4.05	7.49	16.09	3.19	0.98	0.74	0.49	0.25
Astrocyte - cerebellum, donor2	11580-120F5	190.84	17.12	7.70	13.69	19.17	7.70	1.88	1.54	0.68	1.20
Astrocyte - cerebellum, donor3	11661-122F5	82.85	2.10	3.57	6.08	3.36	0.42	0.00	0.63	0.00	1.05
Astrocyte - cerebral cortex, donor1	11235-116D2	67.97	1.74	3.49	2.79	2.09	0.35	0.35	0.00	0.35	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	108.06	10.03	4.69	5.99	11.32	2.75	0.49	0.16	1.13	1.29
Astrocyte - cerebral cortex, donor3	11392-118C6	94.87	5.22	2.98	3.43	5.52	0.75	0.00	1.19	0.15	1.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	94.84	3.44	3.44	7.23	3.56	0.57	0.46	0.92	0.34	0.46
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	88.20	3.26	2.63	6.14	3.88	0.50	0.25	0.75	0.63	0.50
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	80.91	3.98	2.50	5.35	4.21	0.34	0.46	0.46	0.34	0.34
Basophils, donor1	12241-129G9	87.09	3.40	3.40	5.49	5.49	0.26	0.26	0.52	0.26	0.26
Basophils, donor2	12242-129H1	63.50	0.72	2.16	3.97	3.97	0.36	0.00	0.72	0.00	0.00
Basophils, donor3	12243-129H2	77.03	1.76	1.47	3.82	2.79	0.15	0.00	0.00	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	109.74	3.45	8.19	6.68	9.70	3.02	0.22	0.43	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	219.91	10.52	15.09	14.63	10.97	4.11	1.83	0.46	0.91	0.46
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	0.00	7.17	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	112.35	30.13	12.55	6.90	6.28	31.38	3.14	1.26	4.39	3.14
Bronchial Epithelial Cell, donor5	11457-119A8	141.41	23.71	12.27	12.48	5.20	12.89	1.04	1.25	1.46	2.08
Bronchial Epithelial Cell, donor6	11461-119B3	125.51	8.52	11.98	14.74	11.98	4.84	1.15	0.92	0.92	1.84
Bronchial Epithelial Cell, donor7	11769-123I5	84.93	3.42	4.50	3.60	6.30	0.90	0.36	0.18	0.18	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	47.51	3.81	0.21	1.03	8.97	1.13	0.00	0.10	0.31	0.21
Burkitt's lymphoma cell line:RAJI	10476-106I8	69.64	2.10	0.47	1.86	9.55	0.00	0.00	0.00	0.23	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	89.86	1.92	15.99	10.23	23.02	0.00	0.64	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	165.47	0.00	31.03	20.68	20.68	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	69.88	0.56	2.25	1.69	3.94	0.00	0.00	0.56	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	59.95	0.74	0.37	3.90	2.04	0.19	0.00	0.00	0.19	0.37
CD14+ Monocytes, donor3	11381-118B4	67.62	0.66	0.88	2.85	1.76	0.00	0.22	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	65.38	0.28	1.13	1.42	1.42	0.00	0.00	0.00	0.00	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	58.76	0.76	1.52	1.90	1.52	0.38	0.00	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	69.04	0.00	0.33	0.99	1.64	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	42.21	4.19	0.87	2.17	2.46	0.72	0.00	0.00	0.00	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	34.40	0.91	0.60	3.32	1.21	0.60	0.00	0.91	0.30	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	47.14	2.13	0.71	1.90	2.13	0.71	0.24	0.24	0.00	0.71
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	29.13	4.02	0.67	2.34	1.84	0.84	0.33	0.00	0.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	32.85	3.04	0.83	1.66	1.66	2.21	0.00	0.00	0.00	1.10
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	35.95	4.71	0.50	3.22	1.49	0.99	0.00	0.00	0.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	33.48	3.13	0.78	1.37	1.17	0.39	0.00	0.00	0.20	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	34.01	1.25	0.89	3.20	1.42	0.18	0.00	0.18	0.18	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	53.54	2.61	0.65	3.26	4.57	1.31	0.22	0.44	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	31.14	2.81	0.47	2.34	1.64	1.17	0.00	0.47	0.23	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	35.91	6.34	0.53	3.70	1.06	1.58	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	43.26	3.33	2.22	2.22	1.11	0.00	0.00	1.11	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	39.12	4.46	1.04	3.12	2.08	0.45	0.00	0.15	0.30	0.59
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	38.31	2.99	0.40	2.99	1.00	0.40	0.20	0.00	0.00	0.40
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	43.31	2.91	1.67	2.50	1.46	1.25	0.00	0.00	0.00	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	38.89	5.95	1.14	4.12	2.29	1.37	0.00	0.00	0.00	0.69
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	27.60	3.39	1.13	1.13	2.49	1.13	0.45	0.23	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	35.35	2.18	0.44	2.62	1.75	2.18	0.87	0.00	0.44	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	43.58	2.42	1.34	3.50	1.88	0.54	0.00	0.27	0.00	0.81
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	45.53	2.44	0.70	2.79	0.87	0.87	0.00	0.17	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	47.13	1.68	0.84	2.95	2.95	0.84	0.00	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	37.11	2.02	1.10	1.84	1.47	0.73	0.00	0.37	0.00	0.37
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	25.72	2.11	0.70	3.17	1.76	0.70	0.35	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	44.31	3.95	2.19	1.75	1.75	3.51	0.44	0.00	0.00	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	36.97	2.96	0.35	1.92	1.74	0.70	0.00	0.17	0.00	0.70
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	36.05	4.46	0.74	1.49	0.74	0.00	0.00	0.00	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	66.39	3.88	1.94	3.02	3.66	1.08	0.22	0.22	0.43	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	37.26	3.28	1.23	4.09	1.23	1.64	0.41	0.00	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	32.92	2.78	0.93	1.62	0.46	1.39	0.23	0.70	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	36.65	3.48	2.32	2.55	1.62	2.09	0.00	0.23	0.23	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	113.78	3.05	0.87	4.58	13.73	0.65	0.00	0.00	0.22	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	113.19	2.54	1.15	5.54	9.47	0.00	0.46	0.46	0.00	1.62
CD14+CD16+ Monocytes, donor3	11912-125G4	102.46	1.95	0.87	3.68	7.80	0.22	0.43	0.22	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	71.79	0.93	0.62	2.02	5.29	0.16	0.00	0.16	0.16	0.31
CD14+CD16- Monocytes, donor2	11799-124C8	57.63	0.17	0.52	2.10	4.02	0.00	0.00	0.00	0.00	0.35
CD14+CD16- Monocytes, donor3	11910-125G2	68.23	1.11	0.67	2.68	1.56	0.00	0.00	0.00	0.00	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	240.63	11.23	5.61	11.48	37.26	0.26	0.26	0.26	1.02	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	192.56	6.37	4.39	7.68	28.76	1.10	0.44	1.10	0.44	3.07
CD14-CD16+ Monocytes, donor3	11911-125G3	197.07	10.11	2.32	6.11	23.16	2.32	0.63	1.47	1.47	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	75.20	0.00	6.10	24.39	0.00	0.00	0.00	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	74.58	2.03	5.42	16.27	1.36	0.00	0.68	1.36	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	90.10	1.04	4.14	20.71	0.00	0.00	0.00	2.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	75.16	4.80	6.40	13.86	5.33	1.07	0.53	1.07	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	76.66	0.54	4.82	17.69	1.61	0.00	0.00	0.00	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	70.19	0.70	3.51	15.44	1.40	0.70	0.00	0.00	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	76.87	1.57	3.92	35.30	0.78	0.00	0.00	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	83.05	0.00	6.59	27.68	3.95	0.00	0.00	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	46.03	0.82	0.82	11.51	0.82	0.00	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	50.05	0.00	2.18	9.43	0.73	0.00	0.73	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	35.84	0.50	2.52	6.06	0.50	0.50	0.00	0.00	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	222.64	4.85	5.25	2.42	22.63	1.21	0.40	0.40	0.40	1.21
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	148.21	3.60	1.60	2.40	13.18	0.00	0.00	0.40	0.00	0.80
CD34+ Progenitors, donor1	11545-120B6	40.16	2.01	28.11	11.04	8.03	0.00	0.00	1.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	75.28	2.81	26.97	14.61	4.49	0.00	0.56	0.56	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	108.59	1.88	13.53	7.14	15.41	1.13	0.75	0.38	0.38	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	113.87	1.35	17.36	8.34	18.04	0.00	0.45	0.68	0.00	0.45
CD4+ T Cells, donor1	11225-116C1	76.41	0.36	4.64	9.28	1.07	0.36	0.00	0.00	0.00	0.36
CD4+ T Cells, donor2	11306-117C1	78.99	2.45	3.67	12.86	1.22	0.00	0.61	1.22	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	68.01	0.91	3.05	10.67	2.74	0.30	0.30	0.00	0.00	1.83
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	81.68	1.02	7.40	11.74	5.10	0.00	0.51	0.26	0.00	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	59.74	0.45	3.14	13.93	2.92	0.22	0.00	0.22	0.22	0.22
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	67.84	1.15	10.92	13.51	4.02	0.29	0.57	0.86	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	91.97	0.00	4.74	13.75	3.79	0.00	0.47	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	77.26	0.70	7.02	13.34	2.11	0.00	0.70	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	82.41	0.00	13.18	16.48	9.89	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	77.75	0.43	5.93	13.44	5.49	0.00	0.29	0.14	0.14	1.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	68.46	0.68	5.76	13.05	1.69	0.17	0.34	0.34	0.17	1.02
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	72.06	1.13	6.61	15.48	3.71	0.16	0.48	0.64	0.00	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	71.28	0.45	2.24	13.45	3.59	0.00	0.00	0.45	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	65.68	0.70	5.59	10.48	2.80	0.35	0.00	0.00	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	86.68	0.00	6.16	13.20	4.40	0.44	0.44	0.00	0.44	0.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	96.56	0.00	11.81	16.87	6.75	0.42	0.84	0.42	0.00	1.69
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	81.65	1.25	11.64	11.64	3.95	0.21	0.42	0.42	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	78.85	1.00	6.35	12.03	2.67	0.67	0.67	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	70.70	1.09	8.16	16.04	2.18	0.27	0.54	0.00	0.00	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	65.39	0.54	8.04	5.90	1.07	0.54	0.54	0.00	0.00	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	104.01	1.79	8.97	8.97	3.59	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	96.79	1.30	6.30	12.61	4.26	0.19	0.56	0.37	0.00	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	78.63	1.30	3.90	7.80	2.17	0.00	0.22	0.22	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	95.41	0.42	3.99	10.51	5.25	0.63	0.21	0.00	0.00	0.21
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	109.72	1.52	6.07	18.71	2.53	0.00	1.01	0.00	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	94.02	0.00	5.63	19.06	0.87	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	80.19	0.00	5.67	10.90	3.49	0.00	0.44	0.00	0.00	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	135.59	0.49	9.90	20.78	4.95	0.00	0.49	0.49	0.00	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	119.09	0.92	17.54	24.00	2.77	0.00	1.85	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	140.98	6.98	12.56	39.08	5.58	0.00	1.40	0.00	0.00	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	150.10	1.94	4.98	23.26	4.71	0.28	0.28	0.28	0.00	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	137.66	1.23	9.08	19.88	5.89	0.00	0.49	0.49	0.00	0.49
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	89.32	4.62	7.70	32.34	1.54	1.54	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	119.61	0.72	11.46	21.85	1.79	0.00	0.72	0.36	0.00	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	145.42	0.00	8.31	30.47	4.15	0.00	0.00	0.00	1.38	0.00
CD8+ T Cells, donor1	11226-116C2	63.84	0.00	5.24	14.08	4.58	0.33	0.33	0.65	0.00	0.65
CD8+ T Cells, donor2	11307-117C2	61.95	0.38	4.13	9.39	0.75	0.00	0.38	0.38	0.00	1.13
CD8+ T Cells, donor3	11383-118B6	77.77	1.01	5.81	15.40	3.53	0.00	0.25	1.01	0.00	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	36.01	1.15	9.63	4.13	1.61	0.46	0.00	0.92	0.00	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	26.36	1.20	5.51	4.31	2.88	0.24	0.72	0.24	0.00	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	27.63	0.27	9.85	5.47	4.38	0.27	0.27	0.00	0.00	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.52	0.30	10.21	3.90	2.70	0.30	0.90	0.00	0.30	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.88	0.72	3.12	6.00	1.44	0.24	0.72	0.00	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	31.61	0.00	7.05	3.87	3.18	0.45	0.45	0.45	0.00	0.45
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	33.68	0.87	10.43	5.00	1.96	0.43	0.65	0.22	0.22	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	33.95	0.79	10.26	6.32	2.63	0.79	0.79	0.26	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	27.91	0.94	8.44	3.52	1.64	0.47	0.47	0.47	0.00	0.47
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	32.00	1.51	7.85	3.32	3.32	0.30	0.00	0.00	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	32.83	0.58	7.84	4.07	1.74	0.29	0.58	0.00	0.00	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	35.44	0.53	6.13	2.66	2.66	0.00	0.53	0.00	0.27	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	22.33	1.31	8.32	4.82	0.88	3.50	1.31	0.44	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	22.77	1.82	6.38	4.10	2.28	4.10	1.37	0.91	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	20.88	0.75	3.73	4.48	0.75	2.24	0.75	1.49	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	37.10	1.80	9.36	5.76	1.44	0.72	1.80	0.36	0.00	0.72
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	34.81	0.00	6.91	5.75	1.73	0.29	0.58	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	39.13	0.71	5.66	5.66	3.06	0.00	0.71	0.00	0.24	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	50.70	0.95	10.14	5.39	1.58	0.63	0.95	0.32	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	42.75	1.85	11.38	3.38	2.46	0.00	0.62	0.00	0.31	0.92
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	36.87	1.60	13.79	4.17	2.89	0.00	0.96	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	26.77	1.91	5.74	1.53	0.76	0.00	0.76	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	34.29	0.39	6.70	1.58	2.76	1.18	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	25.72	0.00	3.03	1.51	3.03	0.00	0.00	0.00	0.76	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	17.67	0.80	4.82	0.80	2.41	0.80	0.80	1.61	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	13.29	0.70	6.99	2.80	2.10	3.50	2.10	0.70	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	19.03	2.00	12.02	4.01	3.01	4.01	2.00	1.00	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	107.84	3.66	10.97	3.66	0.00	0.00	0.00	1.83	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	64.23	1.48	6.92	6.42	0.99	0.99	0.49	0.99	0.00	0.99
Cardiac Myocyte, donor3	11686-122I3	87.55	3.37	3.68	3.89	6.52	0.95	0.32	0.42	0.21	0.00
Chondrocyte - de diff, donor1	11261-116G1	137.63	35.71	12.48	10.40	11.09	19.76	3.12	3.12	2.43	0.35
Chondrocyte - de diff, donor2	11338-117F6	97.02	8.88	20.97	13.15	4.98	3.55	2.13	2.13	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	123.22	11.04	19.34	20.71	10.35	3.98	3.30	1.93	0.46	1.14
Chondrocyte - re diff, donor2	11339-117F7	225.60	10.74	3.58	3.58	13.43	1.79	0.00	0.90	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	106.76	1.21	6.47	8.09	2.83	1.21	0.00	0.81	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	77.00	3.33	5.62	2.98	5.85	0.69	0.23	0.11	0.23	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	76.10	3.42	2.99	2.78	4.28	0.43	0.00	0.43	0.64	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	72.66	3.01	3.01	3.10	4.25	0.44	0.18	0.71	0.27	0.27
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	74.46	7.34	3.39	4.95	2.29	0.46	0.64	0.37	0.09	0.37
Corneal Epithelial Cells, donor1	11526-119I5	180.93	18.22	11.64	9.88	14.93	14.27	0.44	0.00	1.54	0.44
Corneal Epithelial Cells, donor2	11606-120I4	79.63	2.28	4.55	1.14	5.69	1.14	1.14	0.00	0.00	1.14
Corneal Epithelial Cells, donor3	11687-122I4	135.74	11.76	6.65	7.16	12.78	9.97	0.77	0.26	0.77	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	52.50	1.32	5.45	1.82	2.15	0.00	0.33	0.33	0.17	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	48.89	0.32	8.52	2.21	1.26	0.00	0.00	0.63	0.32	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	65.56	0.00	3.45	3.45	3.45	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	65.87	2.38	5.18	2.81	2.48	0.54	0.00	0.00	0.00	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	57.40	1.37	4.78	2.05	2.05	0.34	0.34	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	122.09	3.26	10.45	6.53	1.96	0.00	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	91.47	1.45	6.29	4.36	0.48	0.00	0.48	0.48	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	95.23	10.84	8.51	5.84	5.67	3.50	0.50	0.33	0.50	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	95.64	9.39	13.50	12.32	5.87	5.87	4.69	1.17	0.59	0.59
Endothelial Cells - Aortic, donor2	11340-117F8	91.34	8.48	17.25	7.07	7.35	2.83	0.28	0.85	0.85	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	94.76	8.65	12.98	10.22	9.83	4.33	3.15	1.18	0.39	0.39
Endothelial Cells - Artery, donor1	11264-116G4	85.52	11.05	9.31	9.60	4.07	2.33	2.91	1.75	1.16	0.87
Endothelial Cells - Artery, donor2	11341-117F9	85.17	10.82	6.12	3.29	5.18	3.53	1.41	0.71	0.47	1.41
Endothelial Cells - Artery, donor3	11413-118E9	92.91	14.02	11.57	7.71	6.66	5.08	0.88	1.23	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	45.44	4.65	6.43	4.43	2.88	1.55	0.89	0.66	0.22	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	52.94	5.17	7.61	3.35	1.83	3.35	1.52	0.00	0.61	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	52.72	3.38	4.79	2.82	0.56	2.26	0.85	0.00	0.56	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	68.34	5.35	7.13	7.13	2.67	1.49	1.49	0.89	0.59	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	64.04	7.29	11.98	10.93	4.69	4.69	0.52	0.52	0.52	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	66.78	1.84	6.38	7.66	1.56	0.57	0.57	0.14	0.43	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	87.23	11.60	10.40	9.20	5.20	2.40	0.40	0.00	0.80	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	78.09	3.14	13.10	5.77	3.67	2.62	2.10	0.00	1.05	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	68.58	4.47	2.86	4.22	4.10	0.75	0.12	0.62	0.62	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	68.87	3.69	2.17	3.48	2.17	0.65	0.22	0.00	0.87	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	74.01	6.47	2.56	2.93	2.20	1.95	0.00	0.12	0.61	0.12
Endothelial Cells - Vein, donor1	11267-116G7	81.90	10.24	9.10	2.28	6.83	0.00	0.00	0.00	1.14	0.00
Endothelial Cells - Vein, donor2	11344-117G3	71.95	10.48	4.19	3.49	6.29	3.49	0.00	0.00	2.79	0.00
Endothelial Cells - Vein, donor3	11416-118F3	89.34	4.55	4.87	4.87	4.71	1.26	0.47	0.31	0.00	0.16
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	173.28	1.65	3.30	8.25	4.95	1.65	0.00	3.30	0.00	1.65
Eosinophils, donor3	12246-129H5	117.71	14.27	3.57	0.00	7.13	0.00	0.00	3.57	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	96.02	5.86	14.17	5.38	8.55	2.44	0.73	1.22	0.00	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	93.61	0.00	8.32	4.16	4.16	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	67.73	9.03	10.26	7.39	6.57	3.28	0.82	1.23	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	67.66	22.77	32.52	12.37	13.47	25.62	8.43	5.91	1.53	2.52
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	84.18	7.58	22.32	15.17	12.24	5.09	2.93	1.41	0.33	1.30
Fibroblast - Aortic Adventitial, donor1	11245-116E3	122.61	19.65	18.80	14.55	16.37	10.43	5.09	4.73	0.97	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	68.51	38.89	25.38	11.46	7.23	22.79	7.78	4.78	2.46	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	96.93	11.07	18.56	15.82	8.23	3.59	2.64	2.64	0.84	2.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	52.70	8.96	8.96	10.28	5.01	1.05	0.79	1.05	0.26	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	168.09	23.92	26.91	20.26	10.96	11.29	4.98	3.65	1.00	3.32
Fibroblast - Cardiac, donor1	11268-116G8	98.44	13.16	10.89	10.89	6.80	1.81	1.36	2.27	0.91	0.91
Fibroblast - Cardiac, donor2	11345-117G4	81.10	6.06	5.31	3.79	6.06	0.76	1.52	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	101.57	5.52	8.04	5.84	7.89	1.89	0.79	0.95	0.32	0.95
Fibroblast - Cardiac, donor4	11452-119A3	65.47	5.15	5.15	3.64	2.42	0.61	0.91	0.00	0.91	0.30
Fibroblast - Cardiac, donor5	11456-119A7	71.83	5.20	4.57	4.06	3.55	0.63	1.14	0.38	1.02	0.51
Fibroblast - Cardiac, donor6	11460-119B2	78.22	5.46	6.37	4.55	3.64	1.82	0.45	1.06	0.15	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	103.71	1.61	2.81	4.96	3.89	0.40	0.13	0.27	0.27	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	53.07	0.00	1.73	3.02	3.88	0.00	0.00	0.43	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	96.68	2.93	4.39	2.93	10.25	1.46	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	153.37	12.45	11.07	10.61	17.07	3.00	1.15	2.08	0.92	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	59.02	0.68	5.94	8.31	2.04	0.00	0.51	0.00	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	115.04	33.57	48.13	15.03	8.45	14.56	6.10	3.99	1.41	0.94
Fibroblast - Dermal, donor2	11346-117G5	158.01	38.21	39.62	18.40	25.00	24.53	6.60	6.13	4.25	0.47
Fibroblast - Dermal, donor3	11418-118F5	170.81	35.90	76.52	27.08	14.14	14.51	7.25	6.41	2.66	1.21
Fibroblast - Dermal, donor4	11450-119A1	125.48	26.11	7.35	9.50	11.76	6.44	2.15	1.02	1.02	1.24
Fibroblast - Dermal, donor5	11454-119A5	114.44	23.55	8.72	10.47	13.43	8.90	2.09	1.74	1.05	0.87
Fibroblast - Dermal, donor6	11458-119A9	146.18	29.40	10.40	13.64	15.11	12.18	2.27	1.14	2.11	2.11
Fibroblast - Gingival, donor1	11237-116D4	96.41	20.82	24.99	19.99	11.45	13.74	3.75	2.50	1.87	1.67
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	140.96	30.65	44.28	23.84	23.06	22.01	5.50	6.03	1.83	1.83
Fibroblast - Gingival, donor2	11318-117D4	123.75	37.69	14.76	15.42	17.53	15.68	4.09	3.56	1.71	1.32
Fibroblast - Gingival, donor3	11394-118C8	89.53	12.96	24.17	20.01	6.09	4.06	2.03	1.84	1.06	0.39
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	147.52	22.86	46.75	51.94	19.74	14.54	17.66	5.19	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	108.54	11.45	25.55	25.73	8.28	5.29	4.76	3.88	1.06	1.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	214.51	57.99	63.61	44.43	29.78	39.13	17.46	11.22	5.61	1.56
Fibroblast - Gingival, donor6 (control)	11922-125H5	176.34	70.72	68.83	56.39	29.75	80.46	30.29	16.09	5.68	1.22
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	121.39	40.23	34.58	32.82	14.47	42.70	12.00	16.94	4.23	0.35
Fibroblast - Gingival, donor7 (control)	11924-125H7	142.73	41.24	39.19	40.07	21.35	41.53	13.75	9.80	4.83	1.61
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	146.44	41.72	41.72	33.27	24.13	43.09	15.00	11.04	4.50	2.05
Fibroblast - Gingival, donor8 (control)	11926-125H9	174.96	61.65	45.96	41.24	26.11	59.89	21.06	12.94	5.92	2.63
Fibroblast - Gingival, donor9 (control)	11927-125I1	70.87	3.08	16.73	18.20	5.72	1.47	1.61	1.47	0.29	0.73
Fibroblast - Lung, donor1	11270-116H1	114.19	17.67	13.59	4.08	9.52	2.72	5.44	0.00	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	116.39	14.92	22.38	13.43	11.94	10.45	1.49	1.49	1.49	0.00
Fibroblast - Lung, donor3	11419-118F6	182.34	27.43	27.65	14.77	17.94	8.44	1.90	2.53	2.53	1.06
Fibroblast - Lymphatic, donor1	11506-119G3	316.55	43.32	30.82	23.32	20.83	17.49	4.17	0.83	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	142.66	5.59	15.38	15.38	8.39	1.40	1.40	0.00	1.40	2.80
Fibroblast - Lymphatic, donor3	11667-122G2	118.39	8.40	16.23	16.23	8.40	4.48	1.68	1.40	0.28	0.84
Fibroblast - Mammary, donor1	11540-120B1	222.07	43.84	35.73	21.52	19.89	14.61	5.68	1.62	4.87	1.22
Fibroblast - Mammary, donor2	11620-122A9	207.70	31.95	71.90	43.94	27.96	7.99	0.00	11.98	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	154.86	0.00	5.96	23.83	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	122.01	25.80	12.61	12.03	19.59	10.09	2.33	2.72	1.55	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	144.25	40.95	11.68	12.29	17.75	13.80	2.58	1.67	3.34	1.52
Fibroblast - Periodontal Ligament, donor3	11395-118C9	119.34	63.65	22.95	19.89	10.40	41.61	4.59	5.51	3.37	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	178.60	44.65	28.62	29.00	17.55	15.26	7.63	4.58	2.67	2.67
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	170.09	34.29	34.29	34.56	19.71	18.09	9.72	7.29	4.32	4.05
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	112.96	14.61	17.16	17.74	9.39	4.99	4.99	2.55	0.81	0.93
Fibroblast - Pulmonary Artery, donor1	11250-116E8	108.43	12.05	7.41	5.08	10.72	4.20	0.66	1.33	0.99	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	161.33	30.07	26.21	18.49	13.82	21.34	2.24	3.66	1.83	0.41
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	165.05	29.40	17.37	14.03	22.05	10.69	10.02	5.35	4.01	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	114.26	10.28	14.23	9.49	14.63	2.77	1.58	0.79	1.19	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	83.35	26.59	16.07	14.49	11.31	10.91	6.15	3.97	1.79	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	78.68	4.44	8.17	6.04	6.04	1.07	1.24	0.53	0.53	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	121.80	14.58	35.67	12.61	9.46	4.93	2.56	2.37	0.39	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	108.61	28.28	28.58	19.56	9.33	16.25	12.34	4.81	0.90	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	198.85	28.28	31.85	22.78	20.08	9.50	6.59	2.81	1.19	1.84
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	68.08	10.38	14.93	5.31	5.82	2.53	3.80	1.27	0.25	0.76
Fibroblast - skin normal, donor1	11553-120C5	131.59	8.37	19.53	13.45	10.34	2.79	2.30	2.13	0.98	0.98
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	87.42	31.68	17.64	9.62	10.03	15.44	4.81	4.41	2.01	0.80
Fibroblast - skin normal, donor2	11561-120D4	199.02	17.98	19.59	16.78	13.46	7.43	4.32	2.11	1.41	2.11
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	107.90	20.25	25.99	14.81	11.79	10.58	11.18	5.14	0.91	1.51
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	87.98	7.37	20.88	11.60	7.29	1.66	2.40	2.15	0.17	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	97.78	7.35	17.27	18.98	5.64	1.54	2.05	1.88	0.00	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	68.64	16.09	19.71	8.87	11.50	4.93	1.97	1.97	0.00	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	230.41	36.75	28.55	23.97	21.52	15.23	6.07	4.79	2.02	1.92
Fibroblast - skin walker warburg, donor1	11554-120C6	172.73	37.78	28.34	18.39	28.68	17.04	7.08	6.07	1.69	2.02
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	133.30	12.39	28.23	16.78	18.03	4.55	3.61	4.39	0.63	5.80
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	819.91	155.12	132.96	177.28	155.12	22.16	88.64	22.16	22.16	221.60
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	50.55	4.36	3.49	2.61	2.61	0.87	0.00	0.00	0.00	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	69.52	29.30	12.31	6.07	4.85	24.96	2.60	1.91	2.08	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	78.59	24.20	7.81	8.33	2.86	9.63	1.82	0.52	1.82	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	75.63	43.44	11.75	10.73	4.85	31.17	3.07	1.53	4.09	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	55.12	0.00	2.30	3.06	17.61	0.00	0.77	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	56.79	0.64	3.83	2.55	17.87	0.00	1.28	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	95.85	2.57	1.14	2.28	14.83	0.00	0.00	0.29	0.29	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	60.94	0.00	0.83	1.65	5.52	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	56.62	0.00	0.46	1.37	5.02	0.00	0.23	0.46	0.00	0.46
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	75.88	1.39	1.39	1.78	9.71	0.20	0.20	0.20	0.20	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	54.98	0.00	1.32	1.59	5.55	0.00	0.00	0.53	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	57.73	0.00	0.00	0.65	6.20	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	81.81	1.33	1.33	2.65	11.94	0.00	0.00	0.88	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	80.84	0.85	1.98	2.83	17.81	0.28	0.14	0.28	0.00	0.71
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	83.86	0.62	3.20	2.83	11.94	0.25	0.37	0.86	0.00	1.23
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	64.20	1.07	3.49	2.69	16.12	0.00	0.27	0.54	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	104.32	3.35	9.29	8.92	13.50	0.50	1.49	1.49	0.12	0.99
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	113.92	4.84	12.46	10.11	18.13	0.69	1.94	1.66	0.14	1.52
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	75.02	4.88	11.38	11.59	15.45	0.81	1.83	2.44	0.20	1.22
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	86.94	4.11	11.64	7.30	10.27	0.46	0.46	0.23	0.46	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	100.65	4.48	17.81	8.84	11.71	0.50	0.62	1.99	0.25	0.62
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	91.36	2.62	12.90	9.18	11.80	1.53	1.97	0.66	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	82.73	2.36	4.43	4.43	7.98	0.00	0.00	0.89	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	74.07	3.02	5.88	4.45	9.54	0.00	0.48	0.00	0.00	0.79
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	78.20	2.23	6.48	4.69	6.26	0.45	0.45	0.00	0.00	0.45
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	64.52	1.01	3.43	2.42	7.06	0.20	0.00	0.20	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	84.99	2.71	2.54	2.88	8.14	0.00	0.34	1.02	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	71.29	2.84	3.90	3.28	9.40	0.27	0.27	0.18	0.27	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	65.97	2.19	1.98	3.02	3.85	0.21	0.00	0.10	0.00	0.52
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	67.46	1.20	2.73	1.20	3.59	0.34	0.34	0.00	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	71.04	1.55	1.77	1.33	3.98	0.22	0.22	0.22	0.00	0.55
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	59.65	2.00	2.08	2.25	5.41	0.08	0.17	0.25	0.17	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	51.66	2.04	1.43	1.63	5.72	0.20	0.61	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	62.51	0.62	2.68	3.92	5.57	0.21	0.21	0.21	0.00	0.83
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	67.56	0.81	1.61	2.08	2.77	0.23	0.12	0.12	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	59.03	1.17	0.67	1.00	3.34	0.00	0.00	0.67	0.17	0.67
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	54.67	0.66	2.87	1.98	3.31	0.00	0.22	0.66	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	75.64	0.86	2.09	1.97	4.43	0.00	0.12	0.00	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	57.06	1.95	1.30	1.78	4.38	0.00	0.00	0.32	0.00	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	51.31	1.28	2.57	1.60	4.17	0.32	0.00	0.32	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	59.88	1.23	1.23	1.23	1.99	0.00	0.09	0.38	0.00	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	49.98	2.53	0.79	1.11	3.32	0.16	0.00	0.16	0.00	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	55.04	1.82	1.82	1.52	3.04	0.00	0.00	0.30	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	68.68	1.67	1.36	1.99	4.60	0.21	0.10	0.31	0.00	0.31
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	47.42	0.88	0.44	2.20	2.20	0.00	0.22	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	55.83	2.24	2.52	2.24	1.68	0.00	0.00	0.28	0.00	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	55.74	1.67	0.93	1.30	2.87	0.28	0.37	0.09	0.00	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	41.98	1.34	1.34	0.53	3.21	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	58.45	5.20	2.60	3.21	3.37	0.46	0.00	0.31	0.00	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	57.51	3.24	1.30	1.55	4.66	0.91	0.13	0.26	0.00	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	47.98	0.81	1.90	2.44	1.90	0.00	0.00	0.27	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	53.46	1.66	2.58	2.58	3.32	0.18	0.55	0.55	0.00	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	52.42	0.44	2.41	3.29	3.51	0.00	0.00	0.22	0.00	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	35.70	0.00	0.99	1.98	0.00	0.00	0.00	0.99	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	69.65	3.03	2.51	4.35	4.62	0.40	0.00	0.26	0.13	0.53
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	69.81	2.42	2.22	2.82	3.23	0.61	0.81	0.20	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	41.43	1.02	2.29	4.57	1.78	0.00	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	121.43	2.39	2.99	3.58	23.49	0.20	0.00	0.40	0.00	0.60
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	85.36	0.92	2.47	2.47	19.26	0.00	0.15	0.46	0.00	0.46
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	107.00	0.61	3.27	2.86	19.03	0.00	0.20	0.20	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	64.78	0.94	1.56	2.82	11.89	0.00	0.31	0.00	0.00	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	62.73	0.28	2.54	2.54	14.69	0.00	0.28	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	76.10	0.00	0.92	2.77	12.91	0.00	0.00	0.46	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	108.89	0.00	4.95	2.47	4.95	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	63.05	1.55	1.93	2.32	14.70	0.00	0.77	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	70.60	1.60	4.81	1.60	11.23	0.00	0.00	0.00	0.00	3.21
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	50.43	0.00	0.00	1.74	15.65	0.00	0.00	1.74	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	55.66	0.00	2.28	3.91	8.14	0.00	0.00	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	70.83	0.82	2.47	1.65	10.30	0.82	0.41	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	3.33	3.33	3.33	3.33	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	54.25	0.56	1.12	1.96	7.55	0.00	0.00	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	57.85	0.00	2.94	2.29	6.86	0.00	0.00	0.33	0.00	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	49.49	0.84	0.84	0.84	6.71	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	65.52	0.00	1.59	3.50	7.63	0.00	0.32	0.00	0.00	0.64
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	56.72	0.34	1.70	2.04	8.49	0.34	0.00	0.00	0.00	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	68.91	0.00	0.00	0.00	2.09	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	81.32	1.15	1.72	2.29	9.16	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	63.04	0.59	2.07	2.37	3.26	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	45.74	1.69	0.00	3.39	10.16	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	81.18	0.00	2.07	1.66	8.70	0.00	0.41	0.41	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	61.21	0.46	2.53	3.68	8.05	0.46	0.46	0.46	0.00	0.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	47.42	0.00	0.00	5.27	0.00	0.00	5.27	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	46.90	0.38	3.08	2.69	3.08	0.38	0.00	1.15	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	54.76	0.33	0.98	2.61	3.26	0.00	0.33	0.33	0.00	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	61.53	0.00	2.68	3.34	5.35	0.00	0.00	1.34	0.00	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	94.39	0.39	2.70	2.70	5.78	0.00	0.00	0.00	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	63.33	0.34	2.40	4.45	5.82	0.00	0.34	0.00	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	67.09	0.00	4.97	0.00	7.45	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	53.32	0.00	1.89	3.30	1.42	0.00	0.47	0.00	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	74.83	0.00	1.81	3.02	3.62	0.00	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	55.95	0.51	3.56	4.07	3.05	0.00	0.00	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	76.18	0.40	2.39	4.39	5.98	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	77.95	0.49	2.96	5.92	3.95	0.00	0.00	0.49	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	68.47	0.00	8.26	2.36	3.54	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	71.76	0.00	2.92	1.75	3.50	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	65.39	0.00	3.07	5.71	0.88	0.00	0.00	0.00	0.00	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	54.25	0.85	4.24	3.39	3.39	0.00	0.00	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	60.89	0.60	1.19	2.39	4.18	0.00	0.00	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	62.11	0.97	2.43	3.88	5.82	0.00	0.00	0.00	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	127.83	36.52	25.11	17.12	5.71	13.70	7.99	7.99	5.71	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	76.93	8.32	12.89	13.72	7.07	3.33	2.91	1.66	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	219.27	59.60	49.48	33.73	15.74	48.35	11.24	4.50	2.25	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	54.87	4.44	29.18	13.64	6.66	3.49	1.59	0.32	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	60.15	7.52	39.27	22.14	6.27	10.44	2.51	0.84	0.84	1.25
Hep-2 cells mock treated, biol_rep1	11898-125E8	39.34	1.16	0.46	0.58	3.25	0.12	0.12	0.12	0.12	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	37.14	0.68	0.51	0.84	2.03	0.17	0.00	0.00	0.00	0.51
Hep-2 cells mock treated, biol_rep3	11900-125F1	34.35	1.37	0.00	0.46	2.50	0.46	0.00	0.00	0.68	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	40.01	1.86	0.33	0.22	2.73	0.44	0.00	0.00	0.33	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	35.03	1.72	0.21	0.21	1.29	0.64	0.00	0.00	0.00	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	37.46	0.43	0.00	0.22	1.72	0.00	0.00	0.22	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	37.49	1.37	0.50	0.50	1.99	0.12	0.00	0.12	0.12	0.25
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	34.31	1.03	0.86	0.34	1.54	0.51	0.00	0.34	0.00	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	31.40	2.24	1.28	0.00	1.28	0.00	0.00	0.00	0.32	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	86.18	3.92	6.72	3.36	2.80	1.12	0.00	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	141.09	11.69	11.25	9.52	7.36	6.06	0.43	0.87	0.87	1.30
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	44.94	5.29	5.29	7.93	5.29	5.29	0.00	0.00	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	140.03	3.88	6.70	6.00	10.23	2.12	0.35	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	111.16	0.73	5.81	9.44	8.72	1.45	0.73	1.45	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	91.27	6.12	4.55	3.50	6.82	1.57	0.17	0.35	1.05	0.35
Hepatocyte, donor1	11523-119I2	37.53	1.21	2.42	0.00	0.00	0.00	0.00	1.21	0.00	1.21
Hepatocyte, donor2	11603-120I1	49.56	1.08	0.00	1.08	2.15	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	46.63	1.84	1.23	0.61	0.00	0.61	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	105.74	2.61	2.61	4.57	11.75	1.96	0.00	0.00	0.00	1.96
Intestinal epithelial cells (polarized), donor1	11246-116E4	59.78	1.05	0.70	0.52	6.64	0.35	0.00	0.52	0.00	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	77.52	3.98	2.61	3.02	4.80	0.41	0.14	0.00	0.41	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	41.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	0.00	0.00	0.00	20.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	48.45	1.38	0.00	0.00	5.54	1.38	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	40.04	0.00	0.00	0.00	7.51	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	25.63	2.56	2.56	0.00	5.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	36.57	0.00	4.57	0.00	4.57	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	51.98	0.00	3.25	1.62	6.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	45.02	5.00	0.00	0.00	10.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	29.04	0.00	0.00	0.00	3.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	51.62	0.00	0.00	1.32	5.29	0.00	0.00	0.00	0.00	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	54.32	0.00	2.22	0.00	7.76	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	36.67	5.24	0.00	0.00	10.48	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	42.83	0.00	0.00	0.00	3.78	0.63	0.00	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	54.13	1.55	3.09	0.00	6.19	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	46.51	0.65	0.65	0.65	7.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	51.52	1.61	3.22	0.00	6.44	0.00	0.00	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	36.67	0.00	0.81	0.81	4.07	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	38.62	0.42	2.52	0.00	6.30	0.00	0.00	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	40.18	0.00	1.61	0.00	7.23	0.80	0.00	0.00	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	63.71	2.77	0.92	0.92	2.77	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	48.15	0.94	0.47	0.00	7.08	1.42	0.00	0.00	0.00	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	33.56	0.91	0.00	0.00	8.16	0.00	0.00	0.00	0.00	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	39.82	1.08	1.08	0.00	7.53	2.15	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	45.74	3.81	2.54	0.00	5.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00	0.00	0.00	32.86	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	33.16	0.00	1.91	0.00	8.29	0.64	0.00	0.00	0.00	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	67.44	0.00	1.82	0.00	5.47	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	38.56	0.71	0.71	0.71	3.57	0.00	0.00	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	0.00	0.00	0.00	0.00	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	50.31	0.31	2.47	0.93	5.25	0.31	0.00	0.00	0.31	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	56.19	0.00	0.00	0.00	5.27	0.00	0.00	0.00	0.00	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	34.57	0.00	0.00	0.00	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	43.81	0.00	0.70	0.00	4.87	0.70	0.00	0.00	0.70	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	61.97	0.00	0.00	2.21	2.21	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	0.00	0.00	0.00	9.73	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	53.19	0.87	0.87	0.00	3.49	1.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	58.49	0.00	0.00	0.00	4.50	0.00	0.00	2.25	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	3.48	0.00	0.00	3.48	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	46.94	1.07	0.00	0.00	5.33	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	33.25	0.00	0.00	0.00	5.54	0.00	0.00	0.00	0.00	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	19.95	0.00	2.85	0.00	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	34.06	0.92	0.00	0.00	4.60	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	93.78	0.00	0.00	0.00	12.10	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	49.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	43.35	0.00	1.06	0.00	3.17	0.00	0.00	0.00	1.06	0.00
Keratinocyte - epidermal, donor1	11272-116H3	63.65	5.88	10.69	6.36	6.20	5.47	0.73	0.49	0.65	0.41
Keratinocyte - epidermal, donor2	11349-117G8	93.12	12.30	14.06	7.03	10.54	9.96	2.34	1.17	1.76	0.59
Keratinocyte - epidermal, donor3	11421-118F8	116.43	36.35	12.49	10.70	7.95	22.62	2.37	1.23	1.80	0.85
Keratinocyte - oral, donor1	11251-116E9	140.08	6.92	11.69	9.65	13.17	3.86	1.14	0.91	0.68	0.45
Keratocytes, donor1	11527-119I6	179.14	12.03	22.01	29.23	30.26	3.09	11.35	8.25	0.34	0.69
Keratocytes, donor2	11607-120I5	131.24	29.30	28.12	21.09	25.78	38.67	4.69	2.34	2.34	0.00
Keratocytes, donor3	11688-122I5	49.79	0.79	3.16	2.77	4.94	0.00	0.59	0.59	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	61.54	2.20	0.00	0.00	6.59	2.20	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	52.86	7.55	3.24	3.24	5.39	1.08	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	103.22	6.46	4.04	5.54	6.00	0.69	0.35	0.35	0.00	0.00
Lens Epithelial Cells, donor3	11690-122I7	64.58	1.41	2.32	2.93	3.83	0.20	0.00	0.20	0.10	0.30
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	73.16	7.35	5.45	7.11	4.27	3.44	0.95	0.36	0.24	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	53.86	5.30	4.47	4.47	3.91	0.84	0.84	0.00	0.28	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	49.27	2.36	3.31	4.72	1.89	1.26	0.31	0.31	0.79	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	50.55	9.14	5.91	5.91	2.15	3.76	2.15	1.61	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	58.62	4.10	5.36	4.10	4.10	1.89	0.95	0.95	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	58.00	4.10	3.99	5.07	2.26	2.26	0.43	0.22	0.11	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	45.96	8.21	6.57	6.57	2.05	0.82	1.23	0.82	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	69.78	4.80	6.07	5.56	2.02	1.52	1.01	0.00	0.51	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	59.54	3.80	3.38	5.35	1.83	0.70	0.56	0.56	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	53.00	5.93	11.87	5.54	1.19	6.72	1.58	0.79	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	58.36	5.04	6.79	3.88	2.52	1.74	0.00	0.19	0.58	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	54.25	2.59	8.15	5.74	2.96	2.41	1.11	0.19	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	62.02	6.27	6.27	5.57	2.79	2.79	1.05	0.70	0.00	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	64.88	4.53	5.25	8.11	1.19	1.43	0.48	0.24	0.48	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	65.93	2.20	5.22	3.71	2.75	1.51	0.27	0.27	0.55	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	54.20	7.39	10.47	5.85	4.00	3.70	0.62	0.62	0.92	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	57.67	4.36	6.86	7.17	3.12	2.18	0.31	0.31	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	57.64	4.21	5.86	4.76	2.38	0.91	0.91	0.55	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	59.57	8.89	5.92	3.62	1.97	6.25	0.66	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	61.21	4.69	5.56	4.98	2.05	2.34	0.29	0.59	0.29	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	59.49	3.73	5.73	7.72	4.98	1.00	0.50	0.75	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	44.62	5.82	8.24	6.79	2.42	3.88	0.97	0.97	1.94	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	72.44	4.85	6.19	6.73	2.96	2.42	1.89	1.08	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	64.79	3.33	6.36	4.84	2.12	1.67	0.76	0.76	0.15	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	51.84	7.78	6.74	4.15	3.11	3.11	2.59	0.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	67.21	5.23	7.12	5.23	2.72	2.51	0.63	0.00	0.63	1.05
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	61.35	4.06	4.81	3.01	2.41	0.90	0.60	0.15	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	57.09	9.63	16.51	8.25	2.06	5.50	1.38	0.00	0.69	2.06
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	62.65	5.83	9.22	4.89	2.07	2.82	1.13	0.56	0.38	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	65.53	3.82	5.83	7.10	2.65	1.70	0.74	0.64	0.42	0.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	51.85	8.72	9.69	4.85	3.39	5.33	0.97	0.48	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	65.50	4.30	7.28	5.62	2.32	2.65	1.65	0.00	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	64.55	3.10	6.94	4.58	2.48	0.62	0.99	0.12	0.25	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	56.64	4.44	6.66	4.81	1.85	1.48	0.37	0.37	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	58.06	4.20	5.44	5.44	2.47	1.98	0.49	0.74	0.25	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	64.76	4.67	4.54	3.99	2.89	1.10	0.82	0.14	0.27	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	58.54	7.08	6.43	4.50	2.25	5.15	0.64	0.64	0.64	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	66.34	6.09	9.74	4.56	2.74	2.74	1.22	0.30	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	61.45	2.80	5.60	4.48	2.38	1.54	0.56	0.42	0.14	0.56
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	54.05	8.53	9.24	5.33	2.84	3.56	2.13	0.71	1.07	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	68.84	5.33	9.70	6.79	5.33	3.88	0.97	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	75.47	4.20	9.03	5.76	1.87	1.09	0.62	0.31	0.47	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	67.68	6.09	8.59	5.73	1.43	6.45	1.43	0.72	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	77.42	4.90	11.76	8.82	3.92	3.59	0.98	1.31	0.00	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	68.74	2.83	8.71	4.24	2.12	1.18	0.71	0.24	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	85.02	11.76	9.03	6.56	2.72	5.32	0.99	0.62	0.62	0.74
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	79.40	6.66	8.71	4.35	2.82	3.33	2.56	0.26	0.00	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	75.48	3.28	7.46	5.07	3.58	1.49	0.30	0.30	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	65.71	0.00	0.00	2.27	6.80	0.00	2.27	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	72.11	0.00	1.53	1.53	3.07	0.00	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	64.57	0.00	0.74	0.74	2.97	0.74	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	44.43	0.42	1.27	2.96	3.81	0.85	0.00	0.85	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	60.49	0.00	0.00	2.11	2.81	0.00	0.00	0.70	0.00	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	52.30	1.87	0.93	0.00	0.93	0.93	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	43.28	0.52	0.52	1.55	2.58	0.00	0.00	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	59.47	1.19	0.00	2.38	3.57	1.19	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	60.39	1.36	0.90	1.81	3.39	0.23	0.00	0.23	0.23	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	47.99	0.87	2.04	1.16	4.94	0.00	0.00	0.00	0.00	0.58
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	67.53	0.45	0.90	0.90	5.40	0.00	0.00	0.00	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	64.76	1.63	1.08	1.63	3.12	0.54	0.00	0.00	0.00	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	57.51	1.03	0.51	1.03	2.57	0.51	0.00	0.51	0.00	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	71.98	0.35	0.71	0.35	3.18	0.00	0.00	0.00	0.71	0.71
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	49.97	0.67	1.33	2.00	3.33	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	47.37	0.51	1.53	2.55	6.62	0.51	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	76.31	0.53	0.80	1.87	4.00	0.27	0.00	0.00	0.27	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	61.78	0.94	1.51	1.32	4.16	0.19	0.19	0.00	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	45.40	2.45	0.61	2.45	1.23	0.00	0.00	0.61	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	71.76	4.08	1.63	0.82	4.89	0.00	0.00	0.00	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	71.84	2.08	1.25	1.67	3.96	0.42	0.00	0.21	0.00	1.25
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	53.53	0.28	1.40	1.40	3.36	0.00	0.00	0.56	0.28	0.56
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	78.31	0.00	2.06	1.03	4.12	0.00	0.00	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	62.13	0.87	1.74	1.74	2.32	0.58	0.00	0.29	0.58	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	53.21	1.79	1.49	2.09	4.48	0.90	0.30	0.00	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	75.80	0.55	1.11	1.66	6.64	0.00	0.00	0.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	71.05	1.06	2.47	1.06	2.83	0.00	0.00	0.35	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	58.27	1.11	0.37	1.11	2.58	0.74	0.00	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	74.83	1.15	6.91	3.45	2.30	0.00	0.00	0.00	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	63.70	1.54	1.92	3.45	4.22	0.38	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	51.52	0.57	0.00	1.13	4.53	0.57	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	81.23	0.82	0.82	0.00	1.64	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	54.23	0.90	0.45	1.36	2.71	0.45	0.00	0.00	0.00	1.81
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	58.89	0.72	2.87	2.87	2.87	0.00	0.00	0.00	0.00	2.15
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	100.09	2.24	2.99	1.49	3.73	0.00	0.00	0.00	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	70.60	0.74	1.49	1.49	5.95	0.00	0.00	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	55.57	0.86	2.58	1.29	5.60	0.43	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	82.20	1.71	1.71	2.57	4.28	0.00	0.00	0.00	0.00	0.86
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	80.30	1.00	1.33	1.00	3.66	0.67	0.33	1.00	0.00	2.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	64.55	1.81	0.60	2.41	6.03	1.81	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	76.08	0.00	1.42	2.84	4.98	0.00	0.00	1.42	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	71.84	1.03	1.72	1.03	5.16	0.00	0.34	0.34	0.69	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	62.26	0.54	1.07	1.61	4.29	0.54	0.54	0.00	0.00	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	85.52	2.02	2.02	2.02	3.37	0.67	0.00	0.67	0.67	2.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	68.16	1.85	4.44	2.96	3.33	1.11	0.00	0.37	0.74	2.22
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	84.89	0.00	0.00	1.16	4.65	1.16	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	82.50	1.06	0.00	2.12	3.17	1.06	0.00	0.00	0.00	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	65.22	0.00	1.60	2.40	3.60	0.80	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	37.07	0.00	2.18	2.91	5.81	0.73	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	71.29	0.77	0.00	1.53	3.07	0.00	0.77	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	52.29	0.49	1.48	0.49	5.92	0.49	0.49	0.49	0.49	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	45.16	0.00	2.82	0.00	5.65	0.00	0.00	0.94	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	68.38	1.01	1.51	2.01	3.02	1.01	0.50	0.00	0.50	0.50
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	57.23	0.90	0.90	0.45	1.35	1.80	0.00	0.00	0.00	0.90
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	36.14	0.00	0.00	0.00	1.72	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	82.83	0.89	1.34	1.78	4.01	0.89	0.00	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	51.62	1.17	0.39	0.78	3.91	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	43.54	0.00	0.66	1.98	3.30	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	72.13	1.56	1.04	3.11	5.71	0.00	0.00	0.52	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	78.32	0.88	1.31	1.75	5.69	0.44	0.44	0.00	1.31	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	60.38	0.56	1.12	2.80	3.35	1.68	0.00	0.56	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	59.18	0.88	1.32	2.65	1.32	0.00	0.44	0.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	68.66	2.31	1.54	2.70	5.01	0.00	0.00	1.16	0.00	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	57.72	1.01	1.01	2.03	3.54	0.00	0.00	0.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	72.09	1.44	2.40	1.44	5.29	0.00	0.00	0.48	0.00	0.96
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	64.80	1.19	2.39	3.18	4.37	0.40	0.40	0.80	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	54.08	1.22	1.82	0.61	7.90	0.61	0.61	0.61	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	33.89	0.69	0.00	1.38	4.15	1.38	0.00	0.00	0.00	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	65.74	0.00	1.90	1.90	5.32	0.76	0.00	0.76	0.00	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	53.19	0.52	2.58	2.07	2.58	0.00	0.00	1.03	0.00	1.03
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	63.49	1.81	3.02	0.60	1.81	0.60	0.00	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	65.92	1.90	2.85	2.54	4.12	0.95	0.00	0.32	0.32	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	47.44	2.13	1.60	2.13	3.20	1.07	0.00	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	58.04	1.72	2.87	1.72	4.60	0.57	0.00	0.00	0.57	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	61.71	1.54	2.57	1.54	5.66	0.51	0.00	0.00	0.00	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	59.42	0.71	2.83	1.41	3.54	0.00	0.71	0.00	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	65.26	1.70	0.57	2.84	2.84	1.13	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	65.73	4.16	2.50	2.50	7.07	0.42	0.42	0.42	0.00	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	58.73	0.00	0.78	1.57	1.57	0.00	0.78	0.00	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	59.71	1.25	2.92	3.34	4.59	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	62.26	1.39	3.25	0.93	4.18	0.46	0.00	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	46.16	1.34	2.01	0.67	2.68	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	72.71	1.07	2.67	1.07	4.81	0.00	0.00	0.00	0.00	1.07
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	74.76	3.23	2.42	2.42	8.89	0.00	0.00	0.00	0.00	0.40
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	59.65	0.00	0.92	2.75	2.75	0.00	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	65.79	0.00	2.67	2.67	2.67	0.89	0.89	0.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	62.69	1.14	2.85	2.85	2.85	0.57	0.57	0.57	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	50.62	1.53	1.53	3.07	4.60	0.77	0.00	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	62.38	2.74	4.92	4.38	8.75	0.55	0.00	0.55	0.00	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	62.36	1.78	2.67	3.12	3.56	1.34	0.45	0.45	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	76.43	2.34	2.86	1.56	5.46	0.78	0.78	0.52	0.00	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	78.91	1.99	3.32	3.98	1.99	0.00	0.00	0.00	0.00	1.99
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	70.67	0.00	4.16	2.08	0.00	2.08	0.00	0.00	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	46.95	1.14	0.68	1.37	2.28	0.46	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	54.32	3.12	3.30	0.92	0.55	0.73	0.00	0.00	0.18	0.18
Macrophage - monocyte derived, donor3	11389-118C3	62.79	1.44	1.31	1.70	1.84	0.13	0.00	0.39	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	97.18	20.18	13.28	9.03	3.19	20.18	2.12	1.59	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	92.38	6.02	6.97	2.69	6.50	3.01	0.32	1.43	1.11	0.32
Mallassez-derived cells, donor3	11930-125I4	101.74	15.43	14.04	8.06	6.67	10.56	1.39	0.69	1.11	1.67
Mammary Epithelial Cell, donor1	11273-116H4	124.45	20.23	29.79	20.43	16.34	14.05	4.58	2.39	2.29	0.10
Mammary Epithelial Cell, donor2	11350-117G9	143.04	43.14	25.19	21.72	17.37	26.35	4.63	1.74	1.45	0.87
Mammary Epithelial Cell, donor3	11422-118F9	121.97	43.15	19.95	15.46	11.72	31.18	2.99	0.75	1.50	1.25
Mast cell - stimulated, donor1	11487-119E2	201.35	4.07	61.01	9.49	6.78	0.68	4.07	0.68	0.00	0.00
Mast cell, donor1	11563-120D6	139.18	2.92	22.39	12.44	3.57	0.11	0.43	0.65	0.22	0.65
Mast cell, donor2	11565-120D8	89.15	2.08	5.05	8.32	2.97	0.00	0.30	0.00	0.30	0.59
Mast cell, donor3	11566-120D9	95.00	0.45	4.73	6.98	2.70	0.00	0.00	0.23	0.00	0.45
Mast cell, donor4	11567-120E1	94.32	0.89	6.03	5.85	2.13	0.18	0.53	0.71	0.00	0.71
Mast cell, expanded and stimulated, donor5	11940-126A5	90.60	1.11	8.10	4.10	1.11	0.22	0.33	0.11	0.22	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	72.96	1.75	41.44	2.92	2.92	0.00	1.17	0.58	0.58	1.17
Mast cell, expanded, donor5	11939-126A4	101.07	1.84	6.08	4.82	2.41	0.23	0.11	0.11	0.23	0.57
Mast cell, expanded, donor8	11941-126A6	84.02	3.35	7.53	8.20	3.01	1.17	0.33	0.33	0.33	0.67
Melanocyte - dark, donor1	11502-119F8	69.25	2.29	1.39	3.08	1.19	0.40	0.00	0.10	0.40	0.00
Melanocyte - dark, donor2	11582-120F7	60.56	2.08	4.85	3.11	1.73	0.35	1.04	0.00	0.00	0.00
Melanocyte - dark, donor3	11663-122F7	64.91	3.84	1.52	1.45	2.17	0.43	0.00	0.00	0.22	0.14
Melanocyte - light, donor1	11274-116H5	29.38	4.23	1.41	0.71	1.65	0.94	0.00	0.24	0.00	0.00
Melanocyte - light, donor2	11351-117H1	30.71	3.41	0.68	4.78	1.36	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	42.49	3.47	0.87	2.60	1.73	0.87	0.00	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	61.33	15.20	1.77	2.19	5.00	3.12	0.31	0.21	0.42	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	40.61	5.11	2.69	2.15	1.61	0.00	0.27	0.81	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	32.68	1.07	2.41	4.82	1.07	0.27	0.54	0.54	0.00	0.27
Meningeal Cells, donor1	11493-119E8	156.44	11.66	2.36	5.46	14.89	1.12	0.50	0.62	0.50	0.12
Meningeal Cells, donor2	11573-120E7	115.76	2.20	0.88	1.32	5.72	0.00	0.00	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	82.72	9.13	4.16	2.61	11.74	2.36	0.65	0.41	0.73	0.41
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	211.02	35.07	23.95	19.68	35.64	13.69	5.42	2.85	3.14	1.14
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	44.58	4.43	6.74	5.23	3.32	1.51	1.41	0.30	0.40	0.30
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	186.61	1.31	69.65	22.34	7.88	2.63	2.63	2.63	0.00	1.31
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	215.85	39.24	49.71	28.78	20.93	27.47	9.16	2.62	2.62	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	144.96	35.88	25.83	17.22	12.92	7.89	2.87	2.15	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	84.50	5.51	7.84	10.59	6.99	0.85	1.27	0.64	0.64	0.64
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	86.46	7.04	12.06	10.05	8.54	5.03	3.02	1.51	0.00	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	251.62	36.48	36.48	22.20	38.02	22.41	5.49	5.05	2.20	1.10
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	277.62	49.68	52.60	30.68	49.68	35.80	10.96	8.04	3.65	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	255.96	41.33	42.35	29.46	36.21	30.90	9.62	6.14	3.89	2.05
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	102.50	3.60	14.54	11.91	7.34	1.11	1.39	0.42	0.28	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	93.67	3.35	8.92	3.35	6.32	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	63.02	2.24	4.74	3.95	3.95	0.39	0.00	0.00	0.26	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	88.73	0.89	6.53	4.45	5.34	0.00	0.00	0.30	0.00	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	77.07	0.00	7.01	7.01	4.67	0.00	0.00	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	160.10	7.68	7.68	14.73	16.65	5.76	1.28	0.00	1.92	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	191.75	37.57	26.94	13.11	18.43	18.79	5.32	4.96	3.90	0.71
Mesenchymal stem cells - hepatic, donor0	11218-116B3	90.69	2.81	4.38	7.82	3.44	0.63	0.31	0.00	0.00	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	109.58	17.42	10.89	5.81	13.06	9.43	0.73	0.73	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	61.26	12.20	7.16	6.89	3.71	6.10	1.86	0.80	1.59	0.27
Mesothelial Cells, donor2	12156-128G5	89.58	20.02	14.01	7.51	2.50	14.01	2.50	2.00	1.00	1.00
Mesothelial Cells, donor3	11402-118D7	69.16	12.21	9.18	7.37	2.53	6.21	1.52	0.94	0.65	0.65
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	76.97	4.05	4.05	4.05	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	65.76	1.72	3.94	2.46	0.99	0.00	0.25	0.25	0.00	0.74
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	45.05	1.47	5.89	5.89	1.18	1.18	0.29	0.29	0.00	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	44.94	0.00	0.00	6.91	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	38.43	0.93	2.48	3.10	2.17	0.00	0.00	0.31	0.00	0.93
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	42.94	1.04	4.15	4.36	0.62	0.62	0.62	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	0.00	4.63	0.00	0.00	0.00	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	49.80	1.75	4.50	4.75	1.50	0.00	0.00	0.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	47.94	0.93	7.45	2.79	1.40	0.00	0.00	0.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	77.86	0.00	0.00	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	54.87	1.42	3.45	2.85	0.81	0.20	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	39.20	1.19	9.90	3.96	0.40	0.79	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	42.76	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	30.97	0.88	1.77	5.31	0.88	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	43.69	1.90	4.18	4.56	1.90	0.38	0.00	0.38	0.38	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	43.42	1.32	3.95	2.63	1.32	1.32	0.00	0.00	0.00	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	40.32	0.85	3.82	3.61	0.21	0.00	0.00	0.21	0.00	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	32.23	0.00	6.45	0.92	0.00	1.84	0.00	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	39.94	0.60	2.98	3.58	0.60	0.30	0.30	0.30	0.00	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	30.18	3.35	6.71	5.03	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	169.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	41.40	1.51	4.01	1.25	0.75	0.50	0.00	0.50	0.25	0.75
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	45.39	2.14	4.99	2.61	0.00	0.71	0.24	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	49.21	1.11	2.21	2.21	0.00	0.55	0.00	1.11	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	43.29	2.30	4.14	2.07	0.69	0.46	0.23	0.00	0.00	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	37.02	2.52	4.84	3.58	0.63	0.84	0.21	0.63	0.00	0.42
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	39.54	1.63	4.69	2.45	1.22	0.00	0.00	0.00	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	34.33	2.15	4.29	2.15	0.43	0.43	0.21	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	45.13	2.89	6.45	4.89	0.67	0.67	0.00	0.22	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	51.59	10.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	29.57	2.19	3.50	2.85	0.66	0.22	0.00	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	32.45	2.53	6.08	5.58	0.51	0.51	1.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	59.65	4.97	4.97	4.97	0.00	0.00	1.66	1.66	1.66	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	33.97	3.26	4.08	5.44	1.63	1.36	0.00	0.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	39.70	3.23	5.29	4.71	1.18	0.59	0.88	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	34.89	2.18	6.54	4.36	0.00	1.09	0.00	1.09	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	38.44	3.84	3.36	5.29	1.44	0.96	1.44	0.48	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	37.62	4.00	9.61	6.40	0.80	1.60	0.80	0.40	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	68.56	9.60	6.86	2.74	1.37	5.48	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	40.05	6.51	7.01	7.51	2.00	0.50	0.00	0.00	0.00	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	26.95	0.00	0.00	0.00	26.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	61.16	12.23	2.04	8.15	2.04	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	36.35	5.26	7.88	5.69	0.88	0.00	1.31	0.44	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	54.08	12.14	9.93	7.73	2.21	1.10	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	64.68	12.17	5.76	3.84	0.64	1.28	0.64	0.00	1.28	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	50.82	5.45	6.69	6.45	0.99	0.50	1.24	0.25	0.50	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	49.41	7.65	8.35	5.57	2.78	1.39	1.39	0.70	1.39	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	90.60	19.89	17.68	11.05	0.00	6.63	4.42	0.00	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	57.78	7.86	5.81	10.94	1.03	1.71	2.05	0.68	0.34	0.68
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	50.33	7.88	10.94	9.63	1.31	2.63	1.75	0.44	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	67.82	12.07	6.75	9.94	3.20	3.55	1.07	0.71	0.36	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	54.71	11.50	12.34	9.82	2.52	2.24	3.09	0.56	0.84	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	61.93	11.22	10.39	10.39	0.83	4.57	2.08	0.83	0.42	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	79.84	19.81	9.32	12.24	1.17	2.91	3.50	0.58	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	50.98	8.75	7.54	12.07	2.41	2.41	1.21	0.30	1.81	0.60
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	60.10	11.69	14.61	8.77	2.09	2.09	1.67	0.42	0.42	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	72.19	21.66	7.22	14.44	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	55.41	10.16	8.31	6.46	0.92	0.92	1.85	1.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	67.73	11.38	9.68	11.38	1.71	4.55	1.71	0.57	0.57	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	75.45	8.98	7.19	12.16	1.66	1.80	2.21	1.38	0.69	0.69
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	67.12	15.81	10.11	10.88	2.07	2.59	3.11	0.78	1.04	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	57.48	13.30	12.87	12.44	3.43	3.86	2.14	0.86	0.86	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	67.97	12.07	8.26	5.08	2.54	2.54	0.64	0.64	0.64	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	49.11	13.08	6.41	8.01	2.67	2.67	2.14	0.53	1.60	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	51.48	5.69	5.39	6.29	1.50	1.20	1.20	0.00	1.80	0.90
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	55.51	4.52	3.53	6.78	0.99	0.85	0.85	0.42	0.00	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	54.15	14.65	7.96	13.06	2.55	1.91	1.27	0.96	0.64	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	78.50	14.37	11.06	13.71	1.99	3.54	2.43	0.66	0.66	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	56.50	10.62	7.58	10.62	3.03	1.14	1.52	1.52	1.14	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	59.38	9.38	8.81	8.81	2.56	0.57	3.13	0.28	0.28	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	72.76	10.57	6.88	13.03	2.95	1.97	1.72	0.49	0.00	0.74
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	52.79	3.91	1.30	4.56	1.30	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	45.87	5.00	5.00	4.41	0.88	1.18	0.59	0.88	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	68.33	6.63	6.63	5.77	1.73	1.44	1.15	0.58	0.29	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	47.81	0.41	1.24	3.30	0.82	0.00	0.00	0.00	0.00	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	47.65	1.19	2.98	3.87	0.89	0.60	0.30	0.00	0.30	0.30
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	22.60	3.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	3.56	1.78	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	47.97	0.99	0.66	1.31	0.99	0.00	0.00	0.00	0.00	0.66
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	48.39	1.05	2.10	1.05	2.10	0.00	0.00	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	26.09	0.00	0.40	0.79	1.58	0.00	0.00	0.20	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	47.50	0.93	1.86	3.73	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	50.32	0.38	0.75	1.13	1.13	0.00	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	46.34	0.80	2.13	1.33	0.00	0.00	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	41.51	0.45	0.45	0.90	0.68	0.11	0.11	0.11	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	35.36	1.47	1.47	0.74	0.74	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	36.28	0.37	0.00	2.93	0.37	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	43.56	1.56	0.00	0.00	0.00	0.00	0.00	1.56	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	38.48	1.60	1.07	1.07	0.53	0.00	0.00	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	54.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	56.56	1.01	0.00	2.02	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	33.73	1.26	2.95	0.84	0.00	0.00	0.00	0.42	0.00	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	58.56	5.45	1.36	2.72	2.72	0.00	1.36	0.00	0.00	1.36
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	82.65	1.91	4.45	3.81	3.18	0.64	0.64	1.27	0.00	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	103.66	4.86	1.62	6.48	1.62	0.81	0.00	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	27.19	3.02	3.02	4.53	1.51	0.00	1.51	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	51.39	22.84	5.71	0.00	0.00	11.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	75.04	6.52	6.52	9.79	6.52	3.26	0.00	3.26	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	76.04	4.75	4.75	14.26	0.00	4.75	4.75	0.00	4.75	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	50.20	0.00	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	140.25	21.54	17.23	13.57	18.96	11.63	4.31	4.52	1.51	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	108.18	2.61	3.66	9.41	7.84	0.00	0.00	1.05	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	53.40	10.01	28.03	10.01	6.01	6.67	4.67	3.34	0.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	65.94	12.52	19.62	10.02	5.84	14.61	3.76	4.59	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	184.06	26.05	17.11	14.83	28.52	13.88	3.42	2.85	3.04	6.08
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	263.32	44.68	14.36	30.32	23.94	33.51	6.38	4.79	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	22.44	4.08	13.60	4.76	2.04	2.72	2.04	2.72	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	187.44	49.62	80.86	73.51	51.45	18.38	22.05	18.38	3.68	45.94
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	23.02	2.09	6.70	7.53	2.93	1.26	2.51	1.67	0.00	0.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	66.01	12.09	13.25	9.53	9.99	16.27	6.04	5.58	0.93	1.39
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	32.16	2.97	13.51	4.59	4.05	1.89	0.54	1.08	0.00	0.81
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	60.34	5.89	7.15	10.09	4.84	3.15	1.89	1.26	0.63	0.63
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	389.72	11.13	66.81	155.89	66.81	44.54	33.40	33.40	0.00	77.94
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	42.69	7.45	27.30	16.88	5.96	6.45	6.45	1.49	0.00	1.49
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	37.08	2.44	8.66	6.23	2.44	0.81	0.81	0.27	0.27	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	28.79	2.95	12.24	6.57	3.85	3.17	1.81	1.13	0.00	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	33.15	2.45	4.08	3.92	3.59	1.14	0.65	0.65	0.00	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	53.95	3.46	5.83	9.66	3.46	1.82	1.09	0.91	0.18	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	24.93	4.24	10.61	5.83	1.06	1.06	1.59	1.06	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.81	4.20	21.61	9.60	1.20	2.40	3.00	1.20	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	48.57	3.61	6.56	9.19	5.91	0.66	1.64	1.31	0.33	3.28
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	19.51	2.76	5.85	5.20	2.76	1.46	1.79	0.65	0.16	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	56.62	2.82	4.06	9.00	2.12	1.59	0.88	0.88	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	14.06	2.11	11.25	2.11	0.70	0.70	0.70	2.11	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.53	0.92	12.41	6.44	1.38	0.92	1.84	3.22	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	20.24	0.64	5.46	5.14	1.29	0.64	0.32	0.64	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	80.01	5.52	16.90	11.04	8.97	2.76	2.07	3.10	0.00	3.45
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	389.38	37.93	40.46	53.10	35.40	12.64	2.53	10.11	2.53	32.87
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	54.36	2.01	4.01	3.56	2.45	1.11	0.22	0.67	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	24.56	0.85	3.39	3.39	0.85	0.85	1.27	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.24	1.90	7.60	9.02	3.80	1.90	1.42	1.42	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.47	0.43	5.58	3.00	0.00	0.00	0.00	1.29	0.00	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	252.78	9.03	45.14	45.14	9.03	18.06	0.00	9.03	0.00	54.17
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	40.99	1.67	6.33	5.33	2.00	0.33	0.33	0.33	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	39.68	1.80	0.90	4.51	1.80	0.00	0.00	0.90	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	22.62	0.40	2.38	4.36	1.59	0.00	0.40	0.79	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.00	0.93	9.29	4.64	1.86	0.93	1.86	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	31.03	0.76	1.89	4.54	2.65	0.38	0.38	0.38	0.00	0.76
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	34.54	1.30	4.24	4.89	2.61	1.30	2.28	1.63	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	29.20	2.18	4.79	3.92	2.18	0.87	0.00	0.44	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	64.68	1.36	1.81	5.88	0.45	2.71	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	21.17	0.88	3.53	1.76	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	20.61	3.32	3.32	4.65	1.99	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	22.82	0.50	3.97	4.96	0.50	0.00	0.00	0.99	0.00	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	28.33	1.91	6.89	3.83	1.15	0.38	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	39.62	0.60	3.93	2.42	2.72	0.00	0.30	0.30	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	49.51	1.11	4.42	3.76	2.87	0.44	0.66	0.44	0.00	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	12.88	0.68	4.74	2.03	2.71	0.00	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	132.85	10.22	30.66	61.31	15.33	10.22	15.33	5.11	0.00	20.44
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	26.83	0.00	0.61	1.22	0.00	0.00	0.61	0.00	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	24.23	1.89	5.35	2.52	0.63	0.31	0.63	0.31	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	22.09	0.91	2.72	0.91	0.61	0.30	0.00	0.30	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	12.66	0.00	3.96	2.37	0.79	0.00	0.00	0.00	0.00	2.37
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	47.61	0.00	6.80	9.07	3.40	1.13	2.27	1.13	0.00	3.40
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	131.51	20.23	15.17	5.06	25.29	0.00	0.00	5.06	0.00	30.35
Myoblast, donor1	11241-116D8	115.28	50.31	58.76	26.71	20.13	47.33	15.03	12.05	2.48	1.12
Myoblast, donor2	11322-117D8	122.55	26.66	26.66	20.90	10.36	12.47	4.79	3.64	2.69	1.53
Myoblast, donor3	11398-118D3	124.27	25.22	17.49	15.13	13.12	12.78	4.04	3.03	1.01	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	60.42	1.17	0.88	3.21	5.69	0.29	0.00	0.44	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	71.34	0.31	4.61	9.23	1.85	0.00	0.31	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	74.79	1.51	4.82	9.05	1.51	0.00	0.00	0.30	0.00	0.90
Natural Killer Cells, donor3	11387-118C1	81.35	0.18	3.31	7.91	3.13	0.00	0.18	0.55	0.00	0.55
Neural stem cells, donor1	11275-116H6	74.77	1.45	2.18	5.44	4.36	0.00	0.73	0.36	0.73	0.36
Neural stem cells, donor2	11352-117H2	92.43	0.00	0.00	1.93	5.78	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	113.79	4.55	1.14	4.55	17.07	1.14	0.00	2.28	0.00	1.14
Neurons, donor2	11574-120E8	125.71	3.30	0.88	4.40	6.38	0.66	0.22	0.66	0.00	0.44
Neurons, donor3	11655-122E8	74.82	0.82	0.00	4.11	6.58	1.64	0.82	1.64	0.00	0.82
Neutrophils, donor1	11233-116C9	54.75	0.00	0.93	1.86	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	55.08	0.00	2.90	2.90	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	40.93	4.28	2.44	1.22	1.22	1.22	0.61	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	64.71	1.66	14.25	16.03	2.37	0.12	0.36	0.95	0.12	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	60.24	1.95	13.02	16.93	2.93	0.65	1.95	1.30	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	91.25	3.81	10.23	13.64	5.01	0.80	1.00	1.20	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	44.19	4.27	7.02	4.54	2.20	3.58	1.38	0.55	0.00	0.28
Olfactory epithelial cells, donor2	11934-125I8	78.02	10.28	16.07	11.87	7.09	8.40	3.18	3.33	0.72	1.16
Olfactory epithelial cells, donor3	11935-125I9	55.16	5.11	7.15	5.22	4.65	2.84	1.02	1.02	0.34	0.34
Olfactory epithelial cells, donor4	11936-126A1	55.22	10.13	11.30	11.30	3.51	6.92	1.95	1.85	0.58	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	93.28	7.22	1.81	3.01	6.02	1.81	0.00	0.60	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	94.65	10.63	22.12	11.49	8.08	4.89	2.77	2.55	0.43	0.21
Osteoblast - differentiated, donor2	11353-117H3	53.73	2.29	6.86	5.72	3.43	0.00	1.14	1.14	1.14	2.29
Osteoblast - differentiated, donor3	11425-118G3	63.93	4.97	10.55	9.93	2.48	1.86	0.00	1.86	0.62	0.62
Osteoblast, donor1	11277-116H8	235.89	15.63	22.67	26.19	28.53	8.40	2.93	3.91	1.76	0.78
Osteoblast, donor2	11354-117H4	192.43	17.56	14.75	13.34	18.96	9.13	3.51	4.21	1.40	0.70
Osteoblast, donor3	11426-118G4	267.48	20.79	26.66	26.13	19.37	7.46	5.15	3.38	1.96	1.07
Pancreatic stromal cells, donor1	11249-116E7	142.78	27.71	40.10	23.25	18.62	17.86	8.17	8.00	1.85	1.60
Pericytes, donor1	11491-119E6	131.18	2.89	6.45	10.46	5.56	0.45	0.45	0.45	0.11	0.67
Pericytes, donor2	11571-120E5	125.86	1.58	5.21	6.79	3.85	0.23	0.68	0.00	0.23	1.13
Pericytes, donor3	11652-122E5	117.80	9.77	7.53	8.95	8.54	3.66	0.41	0.41	1.63	0.20
Perineurial Cells, donor1	11499-119F5	126.36	12.09	5.76	5.20	12.21	1.70	0.90	0.68	0.68	0.57
Perineurial Cells, donor2	11579-120F4	91.55	3.86	4.14	2.85	2.94	0.37	0.37	0.55	0.18	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	65.34	0.96	2.87	3.82	2.87	0.00	0.32	0.00	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	53.62	1.47	2.45	4.16	0.98	0.24	0.24	0.24	0.24	0.98
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	58.63	0.91	3.49	6.60	2.59	0.26	0.39	0.39	0.00	0.65
Placental Epithelial Cells, donor1	11278-116H9	78.69	2.15	1.20	0.96	13.39	0.48	0.24	0.72	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	47.68	3.33	1.11	2.22	2.22	0.00	0.00	1.11	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	55.95	1.18	3.34	2.94	2.94	1.18	0.00	0.39	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	72.78	2.53	9.81	5.06	3.48	2.53	1.27	0.63	0.63	1.27
Preadipocyte - breast, donor1	11467-119B9	45.77	1.13	4.13	2.06	3.94	0.75	0.38	0.19	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	36.03	5.74	3.13	1.96	2.22	1.57	0.65	0.26	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	94.34	3.38	7.20	6.30	4.50	0.00	0.68	0.68	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	48.38	3.41	2.13	2.24	2.56	1.49	0.43	0.64	0.32	0.43
Preadipocyte - omental, donor2	11329-117E6	73.76	6.55	4.36	3.49	3.49	3.49	0.44	1.31	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	91.82	10.31	5.87	4.15	5.30	5.59	0.72	0.57	0.72	0.14
Preadipocyte - perirenal, donor1	11469-119C2	73.82	2.95	6.89	7.87	3.94	0.98	0.00	0.98	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	209.15	39.93	81.08	38.08	16.89	33.78	10.44	8.60	3.07	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	226.84	61.62	51.00	35.06	15.94	44.80	14.87	8.32	4.25	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	236.87	26.90	45.81	30.65	13.28	10.39	7.32	6.13	2.55	1.70
Preadipocyte - visceral, donor1	11280-116I2	174.19	44.34	41.36	29.43	16.21	32.60	12.67	8.76	5.50	1.12
Preadipocyte - visceral, donor2	11357-117H7	161.98	32.21	35.43	19.33	13.35	17.49	5.52	5.06	5.52	1.84
Preadipocyte - visceral, donor3	11429-118G7	205.64	57.57	47.65	37.62	12.96	43.15	15.46	8.25	5.54	1.78
Prostate Epithelial Cells (polarized), donor1	11253-116F2	55.36	0.91	1.36	0.60	9.96	0.15	0.15	0.15	0.15	0.60
Prostate Epithelial Cells, donor2	11331-117E8	78.68	20.31	11.78	8.40	7.45	16.52	1.49	1.08	1.22	1.90
Prostate Epithelial Cells, donor3	11404-118D9	103.31	16.17	7.72	5.51	9.06	12.80	0.43	0.31	1.71	0.80
Prostate Stromal Cells, donor1	11254-116F3	121.65	15.38	20.05	11.16	15.15	7.40	3.30	3.30	0.80	0.80
Prostate Stromal Cells, donor2	11332-117E9	170.15	34.96	35.86	23.31	17.21	19.72	10.40	8.07	3.59	1.79
Prostate Stromal Cells, donor3	11405-118E1	87.38	8.86	26.17	15.95	6.78	5.53	2.92	2.82	0.31	1.25
Renal Cortical Epithelial Cells, donor1	11516-119H4	131.03	8.76	6.57	4.38	13.50	2.92	0.00	0.36	0.36	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	66.68	4.51	3.95	1.94	5.61	1.59	0.69	0.14	0.35	0.35
Renal Epithelial Cells, donor1	11517-119H5	184.63	12.68	15.22	8.62	23.33	6.09	0.00	0.00	2.54	0.51
Renal Epithelial Cells, donor2	11597-120H4	93.18	10.67	4.98	3.56	7.11	2.85	0.00	0.71	1.42	0.71
Renal Epithelial Cells, donor3	11678-122H4	69.13	2.12	4.55	2.33	5.19	0.95	0.11	0.32	0.11	0.42
Renal Glomerular Endothelial Cells, donor1	11514-119H2	102.81	7.49	2.72	6.13	3.40	2.04	0.00	0.00	0.00	2.72
Renal Glomerular Endothelial Cells, donor2	11594-120H1	85.58	11.45	8.22	6.47	3.77	4.45	1.75	0.27	0.94	1.35
Renal Glomerular Endothelial Cells, donor3	11675-122H1	90.58	13.10	4.66	3.11	6.44	3.11	1.11	0.44	1.33	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	106.47	4.66	9.32	3.99	2.00	2.66	0.00	0.00	0.67	1.33
Renal Mesangial Cells, donor1	11518-119H6	142.84	9.46	7.70	8.58	12.10	3.96	0.88	0.88	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	113.48	6.27	4.39	3.13	8.78	0.00	0.00	1.25	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	117.35	2.77	6.10	6.10	7.77	0.83	0.28	0.83	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	124.82	35.16	9.13	5.10	11.81	10.74	1.34	0.54	3.76	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	83.92	18.13	5.06	6.75	8.01	10.12	0.42	1.27	2.95	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	133.64	13.88	11.19	6.36	12.15	4.63	0.58	0.96	1.35	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	103.45	19.19	2.33	6.74	13.22	9.07	0.26	1.04	1.30	1.04
Retinal Pigment Epithelial Cells, donor1	11528-119I7	80.73	3.98	3.13	3.13	5.12	1.99	0.57	0.00	0.28	0.28
Retinal Pigment Epithelial Cells, donor2	11608-120I6	120.41	10.29	9.26	4.12	15.44	10.29	1.03	1.03	2.06	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	42.65	1.25	1.76	1.25	8.53	0.00	0.50	0.00	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	50.25	1.34	0.40	2.14	0.53	0.53	0.00	0.00	0.13	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	50.92	0.89	3.57	0.89	6.25	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	23.67	0.55	1.65	1.65	9.36	0.00	1.10	0.55	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	55.69	1.74	3.48	1.16	11.02	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	105.71	1.82	1.17	1.56	6.50	0.39	0.13	0.13	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	71.60	1.79	1.09	1.59	6.26	0.00	0.20	0.00	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	81.65	1.67	1.34	1.90	6.36	0.45	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	137.44	3.97	0.74	3.35	8.93	0.50	0.37	0.12	0.12	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	81.12	1.63	1.17	1.98	7.69	0.23	0.35	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	85.06	0.69	1.85	2.54	6.93	0.23	0.23	0.00	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	82.01	0.96	0.82	1.92	4.93	0.14	0.00	0.14	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	84.56	1.06	1.51	2.57	7.11	0.30	0.15	0.30	0.45	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	75.98	0.90	1.08	1.61	7.35	0.18	0.18	0.00	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	96.98	1.72	1.15	1.58	6.03	0.29	0.00	0.00	0.00	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	85.10	1.72	1.93	3.00	6.98	0.11	0.32	0.32	0.00	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	80.76	0.44	1.55	1.11	6.20	0.00	0.22	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	75.51	2.29	1.34	2.29	5.74	0.38	0.00	0.57	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	78.16	0.75	1.12	2.42	4.75	0.28	0.19	0.09	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	68.40	1.50	2.07	1.50	5.26	0.19	0.19	0.19	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	98.60	2.65	0.40	2.12	5.84	0.27	0.40	0.27	0.13	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	90.43	0.88	0.97	1.36	10.71	0.39	0.10	0.00	0.00	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	81.54	0.76	1.91	1.91	6.30	0.38	0.38	0.38	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	100.71	1.82	0.75	2.88	7.05	0.53	0.11	0.00	0.11	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	70.64	2.52	2.52	1.40	6.45	0.00	0.00	0.28	0.28	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	92.29	0.85	1.20	2.56	8.54	0.34	0.00	0.17	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	82.60	2.37	1.09	3.65	7.84	0.00	0.00	0.00	0.00	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	82.90	1.59	0.74	2.58	5.40	0.49	0.00	0.00	0.12	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	96.44	1.34	0.67	1.34	6.45	0.00	0.13	0.27	0.27	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	82.08	0.94	1.65	3.30	10.38	0.00	0.00	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	77.78	1.39	1.19	1.39	5.56	0.00	0.00	0.60	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	79.74	0.70	1.64	2.10	7.25	0.23	0.00	0.23	0.23	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	92.27	1.45	1.66	1.66	6.22	0.21	0.21	0.00	0.41	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	74.33	0.66	1.99	1.55	6.86	0.66	0.44	0.00	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	78.12	1.04	1.25	2.09	6.06	0.21	0.21	0.42	0.00	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	94.48	1.75	0.67	2.02	7.27	0.27	0.00	0.13	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	92.81	2.21	0.85	1.70	6.98	0.00	0.00	0.34	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	82.71	1.16	0.77	1.74	6.36	0.58	0.39	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	94.22	3.27	1.72	3.27	7.74	0.52	0.52	0.17	0.34	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	92.04	2.33	1.10	2.19	9.46	0.00	0.00	0.14	0.14	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	83.56	1.48	2.96	1.81	7.39	0.49	0.00	0.00	0.16	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	87.77	1.36	1.53	2.39	7.16	0.00	0.00	0.00	0.17	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	125.02	1.63	1.63	2.66	10.06	0.15	0.74	0.30	0.30	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	84.23	1.60	3.20	2.40	6.13	0.27	0.00	0.00	0.00	0.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	74.39	0.97	1.94	2.49	4.42	0.14	0.28	0.14	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	82.38	0.95	2.38	2.62	6.67	0.24	0.00	0.00	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	87.27	0.81	0.81	2.62	4.43	0.40	0.00	0.00	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	74.40	0.66	1.88	2.26	4.33	0.00	0.09	0.00	0.09	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	70.22	0.00	6.29	2.10	4.19	0.00	0.35	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	56.51	1.21	2.12	1.21	4.84	0.30	0.00	0.00	0.00	1.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	90.44	1.35	1.71	3.06	4.53	0.37	0.37	0.00	0.12	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	57.49	1.89	2.47	2.62	6.11	0.44	0.00	0.44	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	71.19	0.61	4.26	3.04	6.69	0.00	0.00	0.61	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	73.84	1.51	2.11	3.01	6.93	0.30	0.30	0.00	0.30	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	72.38	0.45	4.75	4.30	6.11	0.00	0.68	0.90	0.23	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	79.98	1.50	2.70	3.29	6.89	0.00	0.60	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	79.23	0.47	2.60	1.77	6.49	0.24	0.24	0.24	0.24	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	64.46	1.92	4.06	3.63	7.26	0.43	0.43	0.21	0.00	2.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	68.51	0.00	4.21	3.00	5.41	0.00	0.60	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	214.78	15.99	7.90	8.84	23.32	5.27	2.07	1.32	0.38	1.50
Schwann Cells, donor2	11578-120F3	102.07	20.41	13.61	23.82	10.21	3.40	0.00	0.00	3.40	0.00
Schwann Cells, donor3	11659-122F3	91.79	7.01	3.94	3.72	8.33	1.53	0.66	0.88	0.00	0.22
Sebocyte, donor1	11220-116B5	136.94	17.53	5.48	9.31	6.57	5.48	2.19	0.00	1.64	1.10
Sebocyte, donor2	11301-117B5	101.10	11.49	13.79	8.73	7.81	6.43	1.84	0.92	2.30	3.22
Sebocyte, donor3	11378-118B1	140.98	16.90	10.92	5.98	13.81	6.39	1.03	2.47	0.82	0.41
Sertoli Cells, donor1	11255-116F4	139.15	19.88	6.63	13.25	8.28	4.97	1.66	0.00	0.00	3.31
Sertoli Cells, donor2	11333-117F1	73.43	2.82	16.95	2.82	5.65	0.00	0.00	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	113.67	5.28	14.96	11.00	13.02	1.67	1.67	1.14	0.44	0.26
Skeletal Muscle Cells, donor2	11358-117H8	71.56	2.17	7.23	5.78	3.61	0.00	0.00	0.00	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	282.58	44.31	20.90	29.26	24.25	13.38	8.36	2.51	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	149.71	14.45	14.30	13.82	10.05	6.76	2.83	1.57	0.94	1.57
Skeletal Muscle Cells, donor5	11455-119A6	118.77	9.96	12.49	7.43	7.58	2.68	1.19	0.89	1.19	1.64
Skeletal Muscle Cells, donor6	11459-119B1	160.67	26.78	10.31	10.62	13.54	8.62	3.08	2.31	1.08	1.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	118.19	4.66	8.32	10.21	6.93	3.02	1.01	0.63	0.76	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	140.12	9.13	16.12	12.98	12.27	4.57	2.14	2.57	0.71	1.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	160.12	20.14	12.00	12.30	13.19	8.23	2.38	2.48	1.29	1.09
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	86.11	1.10	2.27	2.86	4.55	0.42	0.34	0.00	0.08	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	243.18	42.70	28.95	39.81	37.64	12.30	1.45	6.51	2.90	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	138.84	5.23	15.00	15.96	8.67	1.24	1.79	1.38	0.41	1.51
Skin - palm, donor1	10286-104F7	85.96	2.69	5.37	2.69	2.69	0.00	0.00	0.00	5.37	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	58.10	3.89	5.33	3.89	4.61	6.49	0.43	0.00	0.29	0.86
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	19.63	0.82	2.45	0.00	4.09	2.45	0.00	0.00	0.82	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	52.71	2.47	5.32	2.86	5.19	3.76	0.13	0.13	0.39	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	101.48	4.73	9.59	5.42	11.12	2.09	1.11	0.56	0.42	1.11
Small Airway Epithelial Cells, donor2	11334-117F2	100.29	5.49	8.02	5.20	6.19	2.81	0.98	0.56	0.42	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	73.16	6.34	2.96	1.48	5.50	2.33	0.21	0.21	0.42	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	120.97	4.80	5.62	5.62	6.60	3.30	0.52	0.67	0.37	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	205.83	48.45	62.03	43.51	20.68	30.86	9.87	5.86	2.78	3.09
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	72.92	22.46	23.57	10.89	7.34	11.34	4.89	1.56	1.11	1.11
Smooth Muscle Cells - Aortic, donor0	11210-116A4	221.02	49.97	56.43	41.15	19.99	32.33	8.23	5.29	2.94	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	91.71	16.13	18.78	15.47	7.51	9.50	4.64	3.54	2.65	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	192.95	63.00	66.94	32.68	22.05	39.38	7.48	7.88	5.91	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	212.46	67.99	52.53	30.90	20.86	34.77	8.50	6.18	2.32	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	39.03	0.00	2.00	3.00	4.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	129.75	27.01	42.19	23.55	12.78	18.10	4.39	3.59	1.86	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	147.40	14.41	21.28	13.74	11.53	6.87	2.66	2.22	1.77	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	151.46	33.42	25.61	23.43	12.68	23.05	5.38	3.33	2.56	6.40
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	77.16	1.63	2.60	4.56	5.54	0.65	0.65	1.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	83.28	8.56	5.91	3.25	3.25	1.77	1.18	0.89	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	59.51	1.71	2.14	2.14	1.85	0.43	0.28	0.28	0.43	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	206.60	34.16	44.90	27.17	22.45	22.12	6.83	6.51	3.58	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	72.76	2.13	19.18	11.57	4.87	1.22	1.22	0.30	0.61	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	181.34	33.59	57.08	27.02	16.67	11.87	8.33	6.57	3.03	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	30.60	79.57	24.48	6.12	42.84	6.12	18.36	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	137.81	31.95	27.18	26.70	12.40	17.64	5.72	5.25	2.38	2.86
Smooth Muscle Cells - Colonic, donor1	11239-116D6	52.50	1.92	4.13	3.10	3.54	0.88	0.44	0.44	0.59	0.00
Smooth Muscle Cells - Colonic, donor2	11320-117D6	62.85	4.74	3.44	3.01	4.74	0.86	0.22	0.43	0.00	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	80.08	6.93	5.56	4.62	5.35	2.41	0.73	0.52	0.10	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	191.49	56.92	70.53	34.03	22.89	42.85	12.22	7.12	5.41	0.46
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	200.49	67.91	83.00	38.80	21.56	57.13	9.70	11.86	6.47	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	132.99	18.53	26.30	17.93	9.26	15.54	4.18	2.69	2.39	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	158.41	9.22	11.61	9.22	17.75	7.17	1.71	0.68	1.02	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	60.86	1.26	4.71	4.95	3.46	0.24	0.55	0.31	0.08	0.08
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	108.99	46.09	30.70	18.62	23.45	53.64	6.24	7.25	4.43	1.21
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	117.42	60.76	41.87	41.41	13.20	44.83	15.47	10.47	5.69	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	150.35	19.32	32.00	21.74	13.89	10.26	3.62	1.81	1.21	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	148.09	34.18	10.86	13.78	18.28	14.04	3.97	3.18	4.24	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	133.82	14.91	12.65	12.65	11.72	9.45	2.93	1.46	2.13	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	95.29	7.39	14.15	13.15	8.64	3.63	1.13	1.50	0.50	0.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	63.42	2.79	12.43	8.37	5.07	0.00	1.27	0.25	0.51	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	173.24	34.83	67.85	37.99	19.15	19.90	15.23	8.90	4.07	0.75
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	145.53	14.25	61.51	30.01	16.50	14.25	6.00	3.00	0.75	1.50
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	161.53	3.88	6.46	9.05	7.75	2.58	1.29	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	222.30	36.74	44.18	20.00	20.93	35.81	5.12	6.51	4.19	0.93
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	140.36	55.54	31.30	34.33	13.13	49.98	11.11	4.54	4.04	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	99.35	45.44	41.37	28.83	9.72	38.86	6.58	3.13	3.13	3.13
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	126.85	12.68	42.48	24.19	11.80	12.09	6.78	2.65	2.06	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	261.33	67.90	45.74	33.24	29.99	31.66	11.41	7.83	4.83	0.50
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	77.55	2.80	16.82	10.28	4.67	0.93	0.93	0.47	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	121.18	19.86	20.44	13.10	12.95	7.34	2.01	1.15	1.01	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	174.39	30.85	22.44	16.57	14.28	12.75	4.08	2.80	1.53	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	159.08	18.05	17.86	15.79	13.73	4.51	2.63	2.07	1.13	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	158.33	24.32	8.66	9.22	15.93	7.83	2.38	1.26	1.96	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	114.79	6.70	6.45	4.61	9.89	0.84	0.59	0.34	0.50	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	136.66	21.90	8.10	7.62	17.62	12.38	1.43	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	148.75	19.57	21.53	16.15	13.70	8.32	1.96	2.20	2.20	1.96
Smooth Muscle Cells - Uterine, donor1	11258-116F7	142.29	24.53	35.13	18.34	12.37	15.69	8.84	4.86	2.43	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	204.51	55.30	48.28	39.79	19.90	31.89	10.83	6.14	4.10	3.22
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	38.09	1.17	5.05	5.83	2.72	0.58	0.19	0.19	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	52.36	12.96	18.78	7.93	10.05	12.43	3.44	3.44	1.32	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	27.90	5.95	34.59	7.44	5.58	6.70	5.21	3.72	0.37	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	66.48	15.81	47.07	16.89	12.58	29.82	10.78	4.31	1.80	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	69.27	25.27	32.65	21.58	16.18	49.97	12.49	7.67	1.99	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	98.86	26.78	21.66	20.88	24.81	54.35	18.12	12.60	1.18	1.58
Smooth muscle cells - airway, control, donor1	11966-126D4	50.79	12.19	37.58	11.68	9.14	18.03	6.35	4.83	0.76	1.52
Smooth muscle cells - airway, control, donor2	11967-126D5	49.12	9.98	22.36	19.57	7.59	10.38	3.59	1.60	0.80	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	29.26	3.34	12.54	3.76	4.60	2.93	1.25	1.25	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	44.92	4.13	18.79	13.29	6.88	2.75	2.75	0.46	0.00	0.00
Synoviocyte, donor1	11291-117A4	82.14	12.96	20.87	9.76	8.92	6.06	4.21	2.69	1.51	0.84
Synoviocyte, donor2	11368-117I9	119.35	16.09	20.62	17.77	6.54	5.36	3.18	2.18	1.51	0.67
Synoviocyte, donor3	11440-118H9	79.76	10.05	11.84	10.28	4.92	1.79	2.01	0.22	0.22	1.12
Trabecular Meshwork Cells, donor1	11532-120A2	186.17	14.65	12.51	9.29	30.73	5.72	1.07	1.79	1.07	0.71
Trabecular Meshwork Cells, donor2	11612-122A1	154.60	9.91	19.82	11.89	13.87	11.89	3.96	1.98	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	119.48	7.87	7.18	11.81	11.11	1.62	2.08	0.46	0.46	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	114.69	10.39	12.04	10.04	10.47	8.10	1.58	1.58	1.51	0.57
Tracheal Epithelial Cells, donor2	11369-118A1	98.96	8.50	12.37	11.21	11.60	3.09	1.55	0.39	1.16	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	87.62	10.88	10.88	10.31	7.44	6.30	1.15	0.00	1.15	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	47.49	1.35	0.49	0.86	0.74	0.12	0.12	0.25	0.00	0.00
Urethra, donor2	10319-105A4	55.75	0.00	0.00	1.80	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	114.23	7.44	11.16	6.91	5.58	3.72	0.27	0.27	0.53	0.00
Urothelial Cells, donor2	11600-120H7	100.94	4.81	6.01	2.00	2.40	0.40	0.00	0.00	0.40	0.80
Urothelial Cells, donor3	11681-122H7	108.18	6.65	6.88	3.44	3.90	2.52	0.46	0.46	0.69	0.46
Urothelial cells, donor0	11216-116B1	141.98	5.57	5.13	3.12	4.46	2.01	0.00	0.00	0.00	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	108.55	2.67	3.56	8.01	1.78	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	131.52	2.86	2.86	17.16	5.72	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	67.77	0.68	0.68	6.16	3.42	0.68	0.00	0.00	0.00	0.68
Whole blood (ribopure), donor090325, donation1	12176-128I7	56.82	1.03	2.41	4.82	3.79	0.00	1.03	0.00	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	54.62	0.00	3.49	4.65	3.49	0.00	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	77.05	5.21	0.00	5.21	3.12	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	101.87	0.92	2.75	7.34	2.75	0.00	0.00	0.92	0.00	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	57.51	1.83	4.56	4.56	2.74	0.00	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	95.85	4.56	4.56	6.54	8.02	1.48	1.48	1.23	0.62	1.11
Wilms' tumor cell line:HFWT	10597-108E3	113.53	0.00	7.04	14.08	8.80	0.00	0.88	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	103.63	5.31	2.51	0.56	5.87	0.56	0.28	1.12	1.12	0.28
achilles tendon, donor2	10292-104G4	53.73	0.00	2.07	0.00	2.07	2.07	2.07	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	71.13	2.55	0.76	3.82	11.98	0.25	0.25	0.25	0.25	0.76
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	86.14	1.86	0.93	1.63	7.89	0.23	0.00	0.23	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	92.00	1.31	3.68	6.89	4.99	0.24	0.12	0.47	0.00	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	133.61	9.80	2.72	4.35	11.16	3.27	0.27	0.54	1.36	0.82
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	112.71	3.37	2.81	6.18	24.45	0.00	0.56	0.84	0.84	0.84
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	93.47	1.27	7.82	4.86	19.67	0.00	0.21	0.85	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	59.61	0.82	6.53	4.63	14.70	0.00	0.54	0.82	0.00	1.09
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	36.13	2.20	0.44	2.64	5.29	0.88	0.00	0.00	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	95.96	1.63	3.68	5.72	20.01	0.00	0.00	0.82	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	74.16	2.72	2.33	1.94	5.05	1.16	0.39	0.39	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	43.06	1.47	0.18	0.74	18.95	0.00	0.00	0.37	0.18	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	58.51	0.00	7.80	3.90	15.60	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	99.23	0.93	8.83	7.44	16.96	0.70	1.39	1.16	0.00	0.70
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	76.89	2.07	0.52	1.29	12.69	0.52	0.00	0.00	0.26	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	68.97	0.88	1.17	1.75	14.90	1.46	0.00	0.29	0.58	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	50.19	1.39	1.39	1.86	3.25	0.00	0.00	0.00	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	46.88	0.41	0.41	0.41	9.46	0.00	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	40.82	1.84	0.31	0.61	1.23	0.31	0.00	0.31	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	54.62	1.28	0.43	0.85	5.12	0.43	0.00	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	58.23	0.91	0.91	0.61	6.07	0.61	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	55.60	0.48	0.24	0.96	4.57	0.96	0.00	0.00	0.00	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	31.18	1.78	0.45	0.45	10.69	0.89	0.22	0.00	0.45	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	52.70	1.67	4.00	2.00	9.01	1.33	0.00	0.00	0.00	0.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	341.91	3.72	29.73	20.44	53.89	3.72	5.57	3.72	1.86	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	157.82	10.17	35.03	15.07	37.29	1.51	3.01	1.13	0.75	0.38
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	107.72	2.62	3.93	8.29	15.26	0.00	1.74	1.31	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	232.43	7.50	97.47	5.62	44.99	3.75	3.75	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	30.38	0.24	1.41	0.24	0.94	0.94	0.00	0.24	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	40.49	0.93	0.62	0.93	0.93	0.16	0.31	0.00	0.00	0.16
adipose, donor1	10184-103D4	102.62	1.17	2.35	3.52	9.38	0.00	0.00	0.00	0.00	1.76
adipose, donor2	10185-103D5	32.04	0.00	0.41	2.43	1.22	0.00	0.41	0.81	0.00	0.00
adipose, donor3	10186-103D6	49.28	0.27	0.27	1.36	5.99	0.00	0.27	0.27	0.27	0.54
adipose, donor4	10187-103D7	65.87	0.00	2.60	0.00	6.07	0.87	0.00	0.00	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	176.76	7.42	2.68	6.15	2.68	1.74	0.16	0.63	0.32	0.63
adrenal gland, adult, pool1	10081-102A9	36.38	0.00	3.64	0.00	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	67.64	0.27	0.53	4.80	10.27	0.00	0.00	0.13	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	82.89	18.58	8.22	6.07	5.36	4.64	1.43	1.43	1.43	0.71
amniotic membrane cells, donor1	12235-129G3	69.09	4.41	1.39	1.16	0.93	0.46	0.00	0.46	0.23	0.70
amniotic membrane cells, donor2	12236-129G4	84.53	0.68	2.03	1.69	2.03	0.34	0.34	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	73.36	2.95	1.18	2.36	1.77	0.59	0.00	0.59	0.00	1.18
amygdala - adult, donor10196	10167-103B5	94.86	2.37	1.19	3.56	4.74	0.00	0.00	1.19	0.00	0.00
amygdala, adult, donor10252	10151-102I7	117.40	2.43	0.61	4.66	1.62	0.20	0.00	0.20	0.00	1.01
amygdala, newborn, donor10223	10360-105E9	35.83	0.97	1.94	2.58	1.61	0.00	0.65	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	117.91	10.31	14.64	17.95	14.39	3.95	1.78	1.78	0.64	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	56.26	5.07	1.76	3.09	3.31	0.88	0.00	0.00	0.44	0.44
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	76.16	1.34	1.00	1.34	2.34	0.00	0.00	0.00	0.33	0.00
aorta, adult, pool1	10052-101G7	69.04	1.18	2.16	3.33	0.78	0.00	0.00	0.00	0.00	0.00
appendix, adult	10189-103D9	63.65	2.72	1.94	8.15	3.49	0.39	0.39	0.00	0.00	1.55
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	40.93	0.00	0.69	1.03	1.72	0.34	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	77.45	0.00	1.36	1.36	1.36	0.00	0.00	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	102.86	17.53	2.17	5.22	6.95	2.46	0.14	0.29	0.43	0.58
b cell line:RPMI1788	10427-106D4	61.41	0.89	1.64	6.54	2.68	0.00	0.45	0.30	0.00	0.45
basal cell carcinoma cell line:TE 354.T	10702-109G9	115.42	44.95	34.40	18.87	14.98	20.81	8.60	6.66	3.33	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	127.61	154.50	10.92	7.54	13.20	82.66	3.27	1.69	14.88	1.19
bile duct carcinoma cell line:TFK-1	10496-107C1	10.71	0.17	0.00	0.00	0.50	0.00	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	55.36	0.56	2.24	1.68	19.57	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	58.67	0.87	0.76	3.04	1.20	0.43	0.11	0.65	0.22	0.33
blood, adult, pool1	10053-101G8	81.94	0.00	4.43	15.50	2.21	0.00	0.00	2.21	0.00	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	125.03	38.54	25.69	17.13	11.13	14.56	5.14	1.71	3.43	0.86
bone marrow, adult	10192-103E3	75.58	1.35	3.37	5.40	4.72	1.35	0.67	1.35	0.00	1.35
brain, adult, donor1	10084-102B3	72.78	2.05	2.05	1.03	1.03	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	99.00	1.34	1.78	3.90	2.56	0.00	0.11	0.11	0.00	0.89
brain, fetal, pool1	10085-102B4	133.57	0.00	2.67	8.01	2.67	0.00	0.00	2.67	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	97.13	0.66	0.99	2.64	5.29	0.33	0.00	1.32	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	67.78	0.12	1.12	2.37	4.37	0.00	0.37	0.25	0.00	0.25
breast, adult, donor1	10080-102A8	31.57	0.00	0.00	0.63	0.00	0.00	0.00	0.63	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	68.47	1.40	3.68	3.56	5.08	1.02	0.00	0.13	0.25	0.64
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	107.92	2.47	8.04	7.42	7.42	1.24	0.62	0.93	0.00	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	110.28	23.25	15.65	4.83	8.52	11.97	0.23	0.69	4.37	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	45.27	0.00	0.97	1.69	5.08	0.48	0.00	0.00	0.00	0.24
carcinoid cell line:NCI-H1770	10703-109H1	77.11	1.41	0.47	0.47	0.94	0.47	0.00	0.00	0.00	0.94
carcinoid cell line:NCI-H727	10735-110B6	82.14	0.44	0.66	1.20	5.58	0.00	0.00	0.00	0.00	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	36.44	0.95	0.00	0.63	0.95	0.00	0.00	0.00	0.00	0.32
carcinosarcoma cell line:JHUCS-1	10642-109A3	92.10	2.40	4.53	8.52	5.06	0.27	0.27	0.80	0.27	0.53
caudate nucleus - adult, donor10196	10177-103C6	84.05	6.91	1.15	1.15	2.30	0.00	1.15	0.00	0.00	1.15
caudate nucleus, adult, donor10252	10164-103B2	106.59	3.68	1.67	4.35	2.01	0.50	0.17	0.00	0.17	0.84
caudate nucleus, adult, donor10258	10379-105H1	71.83	1.53	3.82	6.11	3.82	0.76	0.00	0.00	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	32.96	0.37	1.46	1.10	2.93	0.00	0.37	0.00	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	110.70	0.00	2.91	2.91	2.91	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	111.03	2.78	0.21	4.70	2.78	0.00	0.21	0.64	0.00	0.21
cerebellum, adult, pool1	10083-102B2	89.00	1.03	3.45	4.83	4.14	0.00	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	24.08	1.66	1.66	2.49	4.98	0.00	0.00	1.66	0.00	0.00
cerebral meninges, adult	10188-103D8	115.98	1.76	3.78	6.05	4.29	0.00	0.00	0.25	0.25	2.27
cerebrospinal fluid, donor2	10294-104G6	45.31	1.46	1.46	1.46	1.46	0.73	0.00	2.19	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	25.45	0.00	0.43	0.29	3.31	0.00	0.00	0.00	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	66.95	4.97	1.82	1.49	5.80	0.99	0.17	0.17	0.50	0.00
cervix, adult, pool1	10013-101C4	62.47	0.73	0.94	4.09	1.15	0.42	0.10	0.10	0.10	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	91.68	6.83	0.56	2.79	3.62	1.39	0.00	0.56	0.28	0.84
chondrosarcoma cell line:SW 1353	10700-109G7	139.77	16.98	1.31	16.98	3.92	11.76	1.31	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	40.76	0.50	0.50	0.37	1.74	0.12	0.00	0.00	0.00	0.00
choriocarcinoma cell line:SCH	10785-110H2	18.11	0.12	0.25	0.25	0.12	0.12	0.12	0.00	0.00	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	24.43	1.19	0.24	0.24	0.71	0.00	0.00	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	58.69	2.56	0.28	0.85	0.85	0.57	0.00	0.00	0.57	0.00
chorionic membrane cells, donor2	12239-129G7	117.03	13.62	7.66	6.36	4.87	2.59	1.09	0.60	0.50	1.09
chorionic membrane cells, donor3	12240-129G8	55.50	1.10	1.10	0.00	1.10	0.00	0.00	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	78.76	2.02	6.06	10.10	22.22	1.01	0.00	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	76.46	0.96	3.65	1.15	7.30	0.00	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	155.64	4.01	18.80	13.09	25.34	0.63	2.11	1.48	0.63	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	49.31	0.77	0.51	0.26	5.39	0.00	0.00	0.00	0.00	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	59.02	2.66	1.69	0.00	6.53	0.00	0.00	0.00	0.73	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	53.35	0.81	1.02	0.20	6.72	0.81	0.00	0.00	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	42.11	0.88	0.59	0.00	2.36	0.59	0.00	0.00	0.00	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	129.01	4.95	3.91	2.87	13.03	0.52	0.00	0.52	0.52	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	122.06	11.43	9.37	3.66	8.23	4.34	0.00	0.23	1.14	2.74
clear cell carcinoma cell line:TEN	10636-108I6	38.00	0.87	0.35	0.35	3.47	0.52	0.00	0.00	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	51.98	1.10	1.28	1.46	4.39	0.00	0.18	0.18	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	39.15	0.00	2.28	2.28	4.18	0.00	0.00	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	45.22	0.00	2.38	1.19	0.00	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	65.80	1.29	1.76	2.12	1.65	0.24	0.00	0.35	0.00	0.59
colon, fetal, donor1	10070-101I7	22.87	0.62	1.85	1.85	0.00	0.00	0.00	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	297.93	4.58	4.58	13.75	27.50	0.00	4.58	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	25.04	25.04	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	15.72	1.70	1.70	1.27	0.85	0.00	0.85	0.42	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	33.36	1.21	4.23	2.11	2.41	0.15	0.15	0.15	0.30	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	32.43	1.69	3.38	3.67	3.38	0.56	0.00	0.28	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	104.04	1.00	0.88	3.21	2.10	0.22	0.11	0.33	0.11	0.22
cruciate ligament, donor2	10295-104G7	42.95	1.62	0.00	0.81	0.81	0.81	0.00	0.00	0.81	0.81
diaphragm, fetal, donor1	10069-101I6	54.57	0.00	0.00	0.00	0.00	0.00	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	89.28	1.68	2.88	4.56	1.92	0.24	0.00	0.24	0.00	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	42.02	1.38	0.23	0.92	3.21	0.00	0.00	0.23	0.23	0.69
ductal cell carcinoma cell line:KLM-1	10438-106E6	78.98	2.56	3.59	1.28	8.98	1.54	0.26	0.00	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	41.40	11.55	10.83	8.67	4.09	2.17	2.17	0.96	0.48	0.48
ductus deferens, adult	10196-103E7	50.33	0.00	0.00	1.50	0.00	0.00	0.00	0.50	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	38.89	0.00	0.00	5.76	1.44	0.00	0.00	1.44	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.97	1.47	2.94	5.89	2.21	0.00	0.00	0.00	0.00	1.47
dura mater, adult, donor1	10041-101F5	68.13	0.99	0.91	1.65	2.15	0.25	0.00	0.08	0.08	0.00
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	35.09	2.66	1.55	1.11	42.64	0.22	0.22	0.89	0.00	0.89
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	42.56	1.86	1.15	0.29	11.18	0.14	0.00	0.29	0.14	0.14
embryonic pancreas cell line:1B2C6	10604-108F1	56.73	25.28	9.25	9.25	7.40	14.18	0.62	3.08	1.85	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	61.45	17.25	19.68	11.20	7.57	5.75	1.82	1.82	1.21	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	71.32	33.34	14.51	8.95	5.87	16.36	4.01	3.40	2.78	0.31
embryonic pancreas cell line:2C6	10603-108E9	101.14	49.91	21.02	13.13	10.51	6.57	0.00	5.25	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	63.35	0.67	2.01	3.35	4.02	0.00	0.00	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	150.43	9.61	12.14	24.29	3.99	1.45	0.54	1.27	1.09	1.09
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	65.61	1.13	1.13	0.80	1.61	0.64	0.32	0.16	0.16	0.48
epidermoid carcinoma cell line:A431	10426-106D3	135.50	25.57	15.12	7.89	27.68	10.67	2.89	1.56	2.22	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	130.88	54.00	11.33	4.40	36.30	21.23	1.43	1.65	4.40	0.44
epididymis, adult	10197-103E8	50.03	0.42	3.35	2.72	0.84	0.42	0.00	0.00	0.21	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	127.56	11.89	4.44	13.66	3.90	5.50	2.66	1.24	1.06	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	46.40	5.90	5.51	6.29	3.15	2.75	2.75	1.18	1.57	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	44.16	1.70	0.26	0.52	1.83	0.52	0.00	0.00	0.26	0.52
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	42.62	0.69	0.39	0.10	2.46	0.89	0.00	0.10	0.10	0.30
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	57.47	2.13	0.67	0.22	4.37	0.34	0.00	0.22	0.45	0.34
esophagus, adult, pool1	10015-101C6	66.47	6.16	1.70	2.02	2.23	3.50	0.11	0.32	0.21	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	78.65	0.50	2.63	7.51	1.13	0.00	0.63	0.38	0.13	0.25
eye - muscle inferior rectus, donor1	10272-104E2	79.68	2.41	0.00	0.00	2.41	0.00	0.00	2.41	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	48.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	77.39	0.00	1.49	2.98	0.00	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	57.32	1.15	1.15	1.15	2.29	0.00	0.00	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	37.89	2.91	0.00	1.46	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	54.66	1.02	1.02	4.07	0.51	0.25	0.00	0.25	0.00	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	56.29	16.93	1.80	1.80	7.44	5.64	0.13	0.13	1.03	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	152.90	34.66	24.22	36.09	21.61	18.99	8.31	6.17	2.85	0.95
frontal lobe, adult, pool1	10040-101F4	100.11	2.81	2.16	4.79	3.47	0.09	0.19	0.56	0.28	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	54.04	1.50	0.90	0.60	2.40	0.00	0.00	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	170.16	5.85	2.01	1.92	8.23	1.55	0.55	0.37	0.73	0.55
gall bladder, adult	10198-103E9	67.36	0.72	0.97	6.76	1.21	0.00	0.00	0.00	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	86.97	0.00	9.13	13.42	2.68	0.00	0.00	0.00	0.00	0.54
gamma delta positive T cells, donor2	11938-126A3	82.92	0.00	8.22	11.95	5.98	0.00	1.12	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	76.88	2.96	3.17	1.90	5.07	1.27	0.00	0.42	0.42	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	67.89	0.00	0.39	1.55	3.29	0.00	0.00	0.19	0.00	0.58
gastric cancer cell line:AZ521	10549-107H9	80.17	1.64	1.15	2.62	1.64	0.49	0.00	0.00	0.49	0.33
gastric cancer cell line:GSS	10560-108A2	85.12	2.75	0.92	1.83	0.92	1.83	0.00	0.00	0.00	0.92
gastrointestinal carcinoma cell line:ECC12	10615-108G3	48.43	0.69	0.46	0.23	2.74	0.00	0.00	0.00	0.00	0.23
giant cell carcinoma cell line:LU65	10487-107B1	15.15	3.44	0.46	0.00	2.64	0.69	0.00	0.00	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	98.95	28.27	34.85	16.52	13.16	12.60	5.18	5.32	1.96	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	69.09	2.24	2.74	1.50	3.24	1.25	0.00	0.00	0.50	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	83.60	4.54	4.86	4.75	3.91	1.48	1.06	0.84	0.21	0.21
glioblastoma cell line:A172, tech_rep2	10444-106F3	90.58	5.62	4.92	6.32	4.49	1.69	0.70	0.00	0.70	0.28
glioblastoma cell line:T98G	10485-107A8	119.20	11.15	6.84	8.50	8.28	3.09	0.99	0.99	1.10	0.77
glioma cell line:GI-1	10413-106B8	49.79	2.93	3.22	3.81	5.27	0.00	0.00	0.29	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	63.42	2.92	3.64	0.73	2.92	0.73	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	144.26	3.17	0.98	2.93	1.71	0.49	0.49	0.49	0.00	0.73
globus pallidus, adult, donor10258	10367-105F7	65.72	0.00	0.00	0.00	0.00	0.00	1.37	1.37	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	26.65	1.07	1.07	0.53	0.53	0.53	0.00	0.53	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	234.93	9.79	12.24	7.34	26.92	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	120.21	10.93	65.57	0.00	10.93	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	120.21	0.00	10.45	26.13	20.91	0.00	5.23	0.00	0.00	5.23
granulosa cell tumor cell line:KGN	10624-108H3	80.96	21.76	8.64	11.20	7.68	25.92	2.88	1.92	1.92	0.32
hIPS +CCl2, biol_rep1	14383-156B9	75.75	1.38	2.75	1.38	11.94	0.00	0.46	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	55.79	0.46	1.37	1.83	11.89	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	52.82	1.93	1.29	1.29	7.73	0.00	0.64	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	18.68	0.00	0.00	2.87	11.50	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	39.09	0.69	0.00	2.74	9.60	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	59.59	2.21	4.41	3.31	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	64.08	2.01	2.87	3.16	2.30	0.00	0.29	0.86	0.00	0.29
heart - mitral valve, adult	10205-103F7	54.71	1.20	2.09	2.09	0.30	0.00	0.00	0.30	0.00	0.60
heart - pulmonic valve, adult	10206-103F8	81.84	0.00	1.83	2.09	0.52	0.26	0.52	0.52	0.00	0.52
heart - tricuspid valve, adult	10207-103F9	79.10	1.67	0.83	0.00	3.33	2.50	0.00	0.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	71.62	2.04	0.82	1.43	0.61	0.20	0.00	0.00	0.20	0.41
heart, adult, diseased, donor1	10051-101G6	83.04	0.43	0.85	0.00	0.85	0.00	0.00	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	89.69	2.99	0.23	0.23	0.46	0.00	0.00	0.23	0.23	0.23
heart, fetal, pool1	10046-101G1	75.57	0.92	2.26	3.18	1.23	0.00	0.00	0.00	0.00	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	86.08	4.32	5.86	2.78	3.39	2.47	0.31	0.00	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	39.24	0.00	2.38	0.00	4.76	1.19	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	62.76	1.88	0.33	0.88	5.19	0.44	0.00	0.55	0.11	0.33
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	62.63	1.82	0.73	1.21	7.04	0.24	0.24	0.36	0.00	0.36
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	55.48	1.62	0.30	1.41	6.16	0.20	0.10	0.40	0.10	0.61
hepatoma cell line:Li-7	10484-107A7	53.38	1.56	0.22	0.33	1.67	0.00	0.00	0.11	0.11	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	62.41	2.51	1.31	2.91	6.83	0.50	0.10	0.40	0.30	0.30
hippocampus - adult, donor10196	10169-103B7	85.17	1.89	1.89	3.79	2.84	0.95	0.00	0.95	1.89	0.00
hippocampus, adult, donor10252	10153-102I9	123.07	4.08	1.43	3.47	1.84	0.61	0.00	1.02	0.20	0.41
hippocampus, adult, donor10258	10374-105G5	53.78	0.00	0.50	3.49	1.99	0.50	0.50	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	34.19	0.70	1.41	1.06	2.82	0.00	0.00	0.35	0.00	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	67.14	0.61	3.66	3.05	21.36	0.00	0.00	1.22	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	54.39	0.79	1.18	1.37	9.62	0.00	0.00	0.20	0.00	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	46.46	0.76	1.27	1.02	15.23	0.25	0.25	0.25	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	46.80	0.00	1.69	0.56	2.26	0.00	0.56	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	50.35	0.00	0.77	1.81	4.13	0.00	0.77	0.26	0.00	1.29
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	40.24	0.00	2.66	1.52	7.97	0.00	0.00	0.38	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	44.08	0.00	0.88	1.17	9.63	0.00	0.29	0.29	0.00	0.29
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	52.35	0.22	1.72	2.15	6.46	0.00	0.22	0.00	0.00	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	41.29	0.00	1.25	3.75	4.59	0.00	0.42	0.00	0.00	0.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	63.93	0.00	0.95	1.66	12.31	0.00	0.24	0.47	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	60.91	0.80	2.25	2.09	11.41	0.16	0.32	0.80	0.00	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	51.17	1.35	1.35	3.37	11.45	0.00	0.67	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	51.48	1.10	1.41	2.66	9.23	0.00	0.63	0.16	0.16	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	57.48	0.49	2.46	2.95	13.76	0.00	0.00	0.49	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	31.42	0.00	0.87	2.62	9.60	0.00	1.75	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	58.04	0.19	2.48	1.91	4.39	0.00	0.19	0.00	0.00	0.76
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	46.66	0.87	0.87	2.62	4.36	0.44	0.44	1.31	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	49.98	0.00	3.00	1.50	3.50	0.00	0.00	0.00	0.00	0.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	40.13	0.00	1.70	1.51	2.64	0.00	0.00	0.19	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	43.20	0.00	2.27	0.91	5.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	34.14	0.00	1.25	2.19	1.88	0.00	0.63	0.63	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	55.85	0.49	2.12	3.10	4.08	0.00	0.65	0.98	0.00	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	62.42	0.00	2.32	3.19	5.52	0.00	0.29	0.00	0.00	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	49.02	0.30	2.09	2.39	7.17	0.00	0.00	0.60	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	55.79	0.37	1.11	1.48	10.35	0.18	0.18	0.18	0.18	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	63.05	0.00	1.43	1.71	8.56	0.00	0.00	0.29	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	69.82	1.22	1.63	2.45	17.97	0.41	0.00	0.00	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	64.08	1.06	2.46	1.06	5.63	0.00	0.00	1.06	0.70	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	41.49	0.32	3.17	0.63	4.12	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	49.93	0.91	0.61	2.42	6.66	0.00	0.61	0.30	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	45.51	0.00	3.10	2.07	6.21	0.00	0.00	0.00	0.00	0.52
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	46.49	0.00	0.66	0.66	0.66	0.00	0.00	0.66	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	42.58	0.51	2.57	0.77	7.18	0.00	0.26	0.51	0.00	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	68.26	1.02	3.07	3.07	8.18	0.26	0.51	0.26	0.00	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	60.58	0.76	3.03	2.27	12.12	0.00	1.51	1.51	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	50.74	0.34	1.01	4.37	10.42	0.00	0.34	0.67	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	66.66	0.72	0.24	2.17	15.21	0.48	0.24	0.24	0.00	0.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	44.57	1.34	3.57	0.89	15.60	0.00	0.00	0.45	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	63.90	0.00	1.46	1.46	9.76	0.49	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	53.48	0.00	1.53	0.61	4.58	0.00	0.61	0.00	0.00	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	94.34	0.00	3.25	3.25	6.51	0.00	3.25	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	40.71	0.00	2.32	1.99	5.63	0.00	0.99	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	53.64	0.00	1.64	2.74	5.47	0.00	0.55	0.55	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	51.03	0.00	1.09	1.81	5.79	0.00	0.72	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	36.65	0.00	0.36	0.71	4.63	0.00	0.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	46.54	0.00	2.39	3.58	8.35	1.19	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	75.97	0.54	1.35	2.03	10.83	0.14	0.27	0.41	0.00	0.27
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	46.87	0.00	1.35	1.08	11.85	0.00	0.27	0.00	0.00	0.54
immature langerhans cells, donor1	11904-125F5	88.14	4.36	5.57	4.12	6.30	4.12	0.00	0.73	0.24	0.73
immature langerhans cells, donor2	11905-125F6	83.97	19.01	5.54	5.54	9.51	41.98	0.00	0.00	2.38	1.58
insula, adult, pool1	10039-101F3	110.34	2.08	2.65	5.77	3.03	0.09	0.00	0.09	0.28	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	27.64	0.65	1.30	0.33	1.30	0.65	0.33	0.00	0.00	0.65
kidney, adult, pool1	10017-101C8	63.78	1.20	0.70	2.20	0.70	0.20	0.00	0.10	0.00	0.10
kidney, fetal, pool1	10045-101F9	61.47	0.71	1.56	1.91	2.12	0.00	0.00	0.28	0.14	0.21
large cell lung carcinoma cell line:IA-LM	10509-107D5	84.50	10.23	9.09	5.82	10.37	1.99	0.57	1.28	0.85	0.43
large cell lung carcinoma cell line:NCI-H460	10839-111E2	33.32	0.28	0.83	1.66	1.24	0.55	0.00	0.00	0.00	0.00
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	59.82	25.69	4.77	5.14	6.97	8.26	1.65	2.02	3.12	0.55
left atrium, adult, donor1	10079-102A7	45.77	0.54	1.09	2.18	2.18	0.00	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	49.55	0.00	0.00	0.51	0.00	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	84.27	2.74	11.49	10.40	5.20	2.19	2.74	2.74	0.27	0.55
leiomyoma cell line:10964C	10569-108B2	110.65	30.54	57.12	28.38	15.45	39.88	6.11	7.54	1.44	1.44
leiomyoma cell line:15242A	10570-108B3	109.78	23.91	48.37	20.65	16.30	30.43	8.15	8.70	2.72	1.09
leiomyoma cell line:15425	10571-108B4	139.13	53.91	73.33	37.15	22.58	67.75	19.18	9.71	4.61	3.89
leiomyosarcoma cell line:Hs 5.T	10722-110A2	95.24	12.70	25.40	6.35	12.70	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	53.32	12.55	8.36	3.14	3.14	3.14	1.05	1.05	1.05	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	135.29	11.10	61.51	27.39	27.63	1.77	4.37	3.07	0.59	0.47
liposarcoma cell line:KMLS-1	10782-110G8	65.45	19.06	14.22	11.56	4.06	6.72	5.15	2.97	1.87	0.94
liposarcoma cell line:SW 872	10726-110A6	122.33	11.21	6.46	8.77	7.80	5.85	2.07	3.66	0.85	0.24
liver, adult, pool1	10018-101C9	52.67	1.94	0.32	0.49	0.32	0.81	0.16	0.00	0.49	0.16
liver, fetal, pool1	10086-102B5	55.50	1.88	0.00	0.94	1.88	0.00	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	78.60	0.44	0.58	3.35	3.06	0.44	0.15	0.15	0.00	0.15
locus coeruleus, adult, donor10252	10165-103B3	109.07	2.95	1.11	3.32	3.14	0.18	0.18	0.74	0.00	0.92
locus coeruleus, adult, donor10258	10375-105G6	44.58	0.28	1.97	3.10	1.97	0.00	0.28	0.85	0.00	0.56
locus coeruleus, newborn, donor10223	10362-105F2	29.44	1.26	0.84	2.10	3.36	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma cell line:A549	10499-107C4	35.43	1.25	0.28	0.55	1.25	0.00	0.00	0.00	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	77.90	0.69	0.69	0.00	1.38	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	196.93	6.20	5.01	7.51	20.70	2.50	0.66	1.19	0.66	0.13
lung, adult, pool1	10019-101D1	54.81	1.30	1.18	2.48	0.35	0.12	0.12	0.47	0.00	0.00
lung, fetal, donor1	10068-101I5	75.63	0.86	2.28	13.70	1.71	0.00	0.29	0.29	0.00	0.57
lung, right lower lobe, adult, donor1	10075-102A3	41.24	2.29	0.46	1.37	0.92	0.00	0.00	0.00	0.46	0.46
lymph node, adult, donor1	10077-102A5	41.66	0.00	2.37	4.73	0.95	0.00	0.00	0.47	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	52.16	1.97	1.53	3.07	1.75	0.22	0.22	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	37.13	1.51	0.45	1.06	2.41	0.30	0.00	0.15	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	86.65	14.44	6.80	3.40	13.59	6.80	0.85	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	93.24	3.11	0.44	0.44	0.89	0.44	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	88.82	1.04	0.62	1.04	0.42	0.42	0.00	0.00	0.00	0.42
mature adipocyte, donor3	12233-129G1	68.27	2.61	0.00	0.24	0.47	0.47	0.00	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	60.80	1.58	0.26	0.79	0.53	0.53	0.00	0.00	0.00	0.79
maxillary sinus tumor cell line:HSQ-89	10414-106B9	57.66	0.24	0.24	0.24	1.67	0.24	0.00	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	94.75	0.00	1.13	2.26	3.38	0.00	0.00	2.26	0.00	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	112.92	2.39	2.21	3.13	3.31	0.18	0.00	0.74	0.18	0.37
medial frontal gyrus, adult, donor10258	10368-105F8	83.55	1.59	1.91	2.54	3.18	0.00	0.00	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	50.75	2.13	0.85	3.41	5.54	0.00	0.85	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	95.68	1.69	2.03	3.88	3.88	0.34	0.00	0.51	0.17	1.01
medial temporal gyrus, adult, donor10252	10156-103A3	122.03	5.94	1.27	3.40	1.27	0.64	0.00	0.21	0.00	0.85
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	52.01	0.00	3.85	0.00	3.85	0.00	0.00	1.93	0.00	1.93
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	244.01	0.00	0.00	14.35	0.00	0.00	0.00	14.35	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	50.25	0.72	1.79	2.87	4.31	0.36	0.00	0.36	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	57.76	1.95	0.00	0.65	1.95	1.95	0.00	1.30	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	87.93	2.63	1.70	2.48	1.39	0.00	0.00	0.31	0.15	0.31
medulla oblongata, adult, pool1	10038-101F2	80.81	1.55	1.55	2.86	2.37	0.24	0.08	0.24	0.16	0.16
medulla oblongata, newborn, donor10223	10361-105F1	37.84	0.35	1.39	2.78	3.12	0.69	0.35	0.00	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	43.62	0.22	1.11	0.00	6.86	0.22	0.00	0.22	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	103.81	9.17	3.79	4.52	10.76	2.08	0.86	0.61	0.86	0.12
melanoma cell line:COLO 679	10514-107E1	31.05	3.31	2.87	1.72	1.44	0.29	0.00	0.14	0.14	0.14
melanoma cell line:G-361	10465-106H6	55.65	0.27	2.17	1.90	3.26	0.00	0.00	0.27	0.27	0.00
meningioma cell line:HKBMM	10691-109F7	92.44	12.12	18.09	8.50	8.50	4.52	1.27	1.63	0.90	1.63
merkel cell carcinoma cell line:MKL-1	10843-111E6	70.49	0.00	1.76	0.88	2.64	0.00	0.00	0.88	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	71.55	0.78	0.78	0.52	3.37	0.00	0.00	0.00	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	222.02	19.33	18.57	22.71	10.74	6.75	3.38	2.15	1.23	1.99
mesenchymal precursor cell - adipose, donor2	11748-123G2	142.33	9.27	9.82	12.91	5.82	0.91	0.73	0.55	0.55	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	145.76	17.81	31.06	14.08	7.45	8.28	3.73	1.24	0.41	1.24
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	149.33	22.62	22.90	23.74	7.73	9.13	4.35	1.55	0.98	1.26
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	119.58	16.56	11.17	16.56	2.89	4.62	2.31	0.58	0.00	0.39
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	65.24	22.90	27.76	15.27	6.94	11.11	3.47	2.08	0.69	3.47
mesenchymal precursor cell - cardiac, donor1	11752-123G6	101.78	16.48	18.02	17.85	7.38	2.23	1.37	0.51	0.17	0.69
mesenchymal precursor cell - cardiac, donor2	11753-123G7	123.41	16.45	21.97	14.26	8.05	3.11	2.07	1.38	0.58	1.27
mesenchymal precursor cell - cardiac, donor3	11754-123G8	152.80	11.80	6.10	11.41	7.83	2.52	1.33	0.93	0.53	0.93
mesenchymal precursor cell - cardiac, donor4	11755-123G9	149.89	20.53	19.99	16.74	6.21	6.08	2.57	2.16	0.95	1.08
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	117.08	33.00	8.39	13.66	4.55	9.39	1.28	0.57	1.00	0.57
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	46.11	6.26	4.28	5.93	1.98	2.31	0.00	0.00	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	135.60	15.91	12.18	13.15	5.12	4.43	0.69	0.69	0.97	0.69
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	124.97	17.45	28.28	21.64	11.52	12.57	4.19	2.79	1.40	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	164.76	16.74	25.32	16.54	7.55	3.27	3.06	1.63	2.04	1.02
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	62.19	12.94	14.02	10.06	5.39	5.03	2.52	0.36	0.72	1.44
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	111.31	8.79	8.48	12.62	3.62	1.86	0.41	0.10	0.21	0.52
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	45.37	28.27	15.28	14.14	4.79	29.87	3.88	3.88	1.82	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	149.78	36.92	34.82	27.27	18.88	16.36	5.45	5.87	1.26	1.26
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	133.15	20.17	14.50	17.19	5.23	5.98	2.39	1.05	1.20	1.20
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	100.31	12.25	6.74	11.20	2.45	2.19	0.61	0.18	0.70	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	73.26	10.31	4.42	12.15	2.58	2.21	0.00	1.47	0.74	1.84
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	69.54	10.87	18.89	9.44	5.72	6.58	3.15	1.43	0.86	1.14
mesenchymal stem cell line:Hu5/E18	10568-108B1	124.62	14.31	20.21	16.42	21.89	8.00	4.21	3.37	2.11	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	118.28	16.90	14.16	14.61	7.31	8.68	3.20	3.20	1.83	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	109.73	13.05	15.60	16.88	7.93	5.37	3.58	2.30	1.79	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	109.94	13.87	16.75	13.87	10.99	11.78	4.97	3.40	1.83	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	98.90	14.17	22.80	13.25	13.56	9.55	1.23	3.08	1.85	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	106.38	15.30	15.77	12.94	8.94	9.88	3.53	4.00	0.47	1.41
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	106.61	12.86	10.83	14.89	10.15	10.15	6.09	1.69	1.69	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	115.93	14.54	16.50	12.97	11.00	11.00	4.72	1.96	1.57	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	102.87	10.66	23.17	14.36	8.80	10.19	3.24	3.71	1.39	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	0.00	48.30	48.30	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	135.84	15.86	19.32	18.46	11.54	10.09	4.90	4.33	1.73	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	114.00	11.60	20.97	12.72	12.72	9.59	4.02	2.68	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	112.24	16.82	16.82	11.06	10.09	8.89	4.81	2.88	1.44	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	125.40	16.13	14.67	14.67	10.27	8.80	3.67	2.20	1.47	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	94.66	14.77	16.78	12.42	6.38	7.72	4.70	2.35	0.34	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	82.69	9.01	14.74	10.64	8.19	9.42	3.28	2.87	0.41	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	97.51	11.60	20.19	11.60	8.59	9.02	5.15	3.01	1.29	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	68.36	8.20	13.67	8.20	5.47	2.73	2.73	0.00	0.00	5.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	77.47	5.16	20.66	15.49	0.00	0.00	0.00	5.16	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	100.03	9.09	22.74	10.72	15.59	9.09	2.27	2.60	1.30	3.25
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	53.83	14.55	14.55	17.46	8.73	2.91	2.91	1.45	1.45	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	106.62	11.19	20.79	14.39	8.00	12.79	2.67	2.67	1.60	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	79.32	6.54	13.90	10.63	5.72	7.36	2.45	3.27	2.45	1.64
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	80.08	5.44	15.16	10.50	8.16	8.55	4.66	1.94	1.55	2.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	77.65	4.20	18.89	12.59	4.20	8.39	6.30	2.10	0.00	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	58.61	6.95	11.92	16.89	7.95	4.97	1.99	1.99	0.00	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	61.97	9.53	4.77	14.30	4.77	4.77	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	71.16	7.71	18.97	12.45	9.49	5.34	4.15	3.56	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	87.73	7.31	25.59	12.18	9.75	8.53	3.66	1.22	2.44	2.44
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	27.05	27.05	0.00	0.00	0.00	27.05	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	95.01	5.07	21.54	13.30	10.77	8.23	3.17	1.90	1.27	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	40.70	0.69	9.66	8.28	2.41	0.34	1.03	0.69	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	40.83	0.00	10.75	6.45	2.15	0.00	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	31.93	0.00	0.00	11.98	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	37.88	6.89	24.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	49.30	2.44	7.74	5.70	0.81	0.00	1.22	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	53.23	0.00	7.15	7.15	3.18	1.59	1.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	49.52	1.77	5.90	3.54	1.77	0.59	0.00	0.00	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	40.52	1.87	3.74	4.36	1.56	0.62	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	26.73	1.34	2.67	4.01	0.00	0.00	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	63.86	4.73	7.10	1.18	3.55	0.00	0.00	4.73	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	51.36	2.57	2.57	5.14	7.70	5.14	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	60.58	2.07	7.57	6.20	4.13	0.69	0.00	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	68.28	3.46	4.45	2.47	3.46	1.48	0.99	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	45.98	7.85	6.73	4.49	0.00	2.24	0.00	0.00	2.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	54.70	3.82	3.82	1.91	1.91	1.91	1.91	0.00	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	74.15	2.42	1.61	3.63	2.82	1.61	0.81	0.40	0.40	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	52.33	4.36	4.36	8.72	4.36	0.00	0.00	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	60.82	11.40	5.07	0.00	5.07	1.27	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	81.32	1.21	4.86	4.86	5.46	0.00	0.00	0.00	0.00	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	54.23	0.00	4.52	4.52	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	55.19	4.12	6.59	1.65	0.00	1.65	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	33.73	0.40	1.98	0.99	1.39	0.40	0.40	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	44.46	0.00	3.24	0.65	2.60	0.65	0.65	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	40.75	1.02	3.06	4.07	2.04	0.00	0.00	0.00	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	70.41	8.51	3.87	11.61	0.77	2.32	1.55	0.00	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	123.08	49.85	14.17	15.36	7.80	12.05	2.36	0.94	4.72	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	58.61	6.49	8.11	6.02	4.17	1.16	2.32	1.16	0.46	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	25.64	17.09	8.55	4.27	0.00	17.09	4.27	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	45.00	26.41	10.48	5.86	6.58	7.09	4.52	4.01	1.75	0.62
mesothelioma cell line:Mero-25	10850-111F4	102.36	6.13	17.25	12.71	25.19	1.82	5.90	5.67	0.45	1.59
mesothelioma cell line:Mero-41	10851-111F5	88.50	3.91	5.62	4.65	10.51	3.42	0.24	2.20	0.00	0.98
mesothelioma cell line:Mero-48a	10852-111F6	85.69	12.40	8.86	7.09	10.63	3.99	0.44	1.11	0.89	0.66
mesothelioma cell line:Mero-82	10853-111F7	106.70	15.51	21.02	19.18	37.06	7.10	9.72	10.25	1.58	1.58
mesothelioma cell line:Mero-83	10854-111F8	65.88	21.45	6.47	8.17	7.15	18.55	3.92	5.62	2.04	0.51
mesothelioma cell line:Mero-84	10855-111F9	47.52	1.77	1.26	1.52	3.29	1.26	0.76	0.51	0.25	0.76
mesothelioma cell line:Mero-95	10856-111G1	51.97	1.45	4.55	1.86	3.93	0.21	0.62	1.45	0.21	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	116.12	37.44	28.82	10.44	14.08	15.24	2.48	3.81	2.32	0.99
mesothelioma cell line:NCI-H226	10846-111E9	91.58	27.69	24.43	19.00	12.67	19.55	7.78	10.14	2.53	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	111.21	9.22	16.06	7.86	7.86	4.78	3.07	3.76	0.51	0.85
mesothelioma cell line:NCI-H28	10845-111E8	40.21	2.54	2.29	3.05	2.54	1.53	0.76	0.25	0.25	0.00
mesothelioma cell line:No36	10857-111G2	41.10	3.91	0.33	0.65	2.28	0.65	0.33	0.00	0.65	1.30
mesothelioma cell line:ONE58	10858-111G3	92.94	19.78	30.89	19.51	13.01	11.11	9.48	6.77	1.08	0.54
migratory langerhans cells, donor1	11901-125F2	44.53	0.58	2.49	0.96	0.96	0.58	0.38	0.19	0.00	0.96
migratory langerhans cells, donor2	11902-125F3	43.72	0.37	0.49	0.85	0.61	0.12	0.00	0.12	0.12	0.37
migratory langerhans cells, donor3	11903-125F4	50.25	0.54	0.00	1.26	0.90	0.18	0.18	0.18	0.18	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	143.32	12.73	7.18	4.90	9.14	1.63	0.33	0.65	1.31	2.94
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	99.82	11.23	1.91	1.48	6.15	4.45	0.42	0.64	0.85	1.06
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	92.83	65.65	7.60	4.61	15.66	26.72	1.15	1.15	6.68	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	61.46	2.47	6.09	8.94	1.52	0.76	0.57	0.00	0.00	0.00
myelodysplastic syndrome cell line:SKM-1	10772-110F7	62.64	1.11	0.37	1.11	13.12	0.74	0.00	0.18	0.00	0.37
myeloma cell line:PCM6	10474-106I6	124.93	1.38	2.37	9.09	8.70	0.40	1.19	0.00	0.40	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	112.62	21.81	4.57	3.55	15.73	6.59	1.01	0.00	1.01	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	190.84	51.39	7.85	8.63	30.01	8.24	1.37	1.77	1.18	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	93.37	4.12	7.80	6.13	8.02	3.34	0.67	0.11	0.56	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	83.17	4.71	8.53	4.56	7.57	2.65	0.29	0.37	0.29	0.29
nasal epithelial cells, donor2	12227-129F4	81.14	10.49	8.83	3.31	7.73	4.97	0.55	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	67.41	1.15	0.46	0.92	5.29	0.00	0.00	0.00	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	86.06	0.75	2.06	1.68	5.61	0.19	0.19	0.00	0.00	0.75
neuroblastoma cell line:NBsusSR	10607-108F4	113.25	0.84	1.05	4.43	8.22	0.00	0.00	0.00	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	70.63	0.37	0.37	1.49	3.17	0.00	0.00	0.19	0.00	0.37
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	47.45	0.00	0.24	3.56	1.66	0.00	0.00	0.24	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	68.42	0.63	0.79	1.90	2.38	0.00	0.00	0.32	0.16	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	63.20	2.42	0.20	1.21	1.81	0.00	0.00	0.00	0.00	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	80.11	3.81	0.64	0.00	2.54	0.64	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	99.81	9.85	7.98	7.98	10.91	5.06	1.33	0.27	0.53	0.27
neutrophil PMN, donor1	12133-128D9	193.37	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	66.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	104.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	9.47
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	90.31	0.17	3.04	7.44	3.55	0.00	0.17	0.51	0.00	0.34
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	72.85	3.20	1.60	2.40	4.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	80.79	7.05	13.14	9.62	6.09	3.21	0.96	3.53	1.60	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	91.97	6.83	16.29	13.40	8.41	2.63	3.42	3.42	0.79	2.10
nucleus accumbens, adult, pool1	10037-101F1	99.55	2.81	2.16	4.87	2.62	0.19	0.00	0.09	0.00	0.19
occipital cortex - adult, donor10196	10172-103C1	111.26	0.00	4.12	2.06	0.00	0.00	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	114.59	2.15	1.34	3.76	1.07	0.54	0.27	0.54	0.00	0.27
occipital cortex, newborn, donor10223	10355-105E4	43.67	1.46	0.73	4.00	2.91	0.36	0.00	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	95.78	1.31	2.62	6.82	1.31	0.00	0.00	0.79	0.00	1.05
occipital lobe, fetal, donor1	10073-102A1	92.26	0.43	0.43	5.58	5.15	0.43	0.00	0.00	0.00	0.86
occipital pole, adult, pool1	10036-101E9	115.11	0.79	2.52	4.97	3.23	0.08	0.16	0.32	0.24	0.39
olfactory region, adult	10195-103E6	103.55	1.91	2.29	4.97	2.29	0.57	0.00	0.57	0.00	0.96
optic nerve, donor1	10277-104E7	98.05	4.00	2.00	2.00	4.00	0.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	32.81	0.80	0.57	1.37	3.76	0.00	0.00	0.00	0.00	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	95.76	1.65	3.43	4.81	9.07	0.27	0.27	0.27	0.27	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	66.71	3.89	10.33	4.06	4.40	0.85	0.34	1.02	0.85	0.85
oral squamous cell carcinoma cell line:SAS	10544-107H4	89.75	8.66	8.43	5.08	10.40	1.04	0.12	0.81	0.46	0.58
osteoclastoma cell line:Hs 706.T	10704-109H2	87.01	3.82	6.47	7.06	4.12	0.88	2.65	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	433.53	121.46	74.75	34.57	67.27	29.90	11.21	9.34	6.54	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	81.01	5.51	7.42	9.12	19.72	0.64	0.64	0.42	0.00	0.42
ovary, adult, pool1	10020-101D2	57.91	0.79	1.05	4.19	1.75	0.26	0.09	0.17	0.00	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	97.71	24.93	5.13	7.52	11.92	12.47	0.92	1.83	1.28	0.55
pancreas, adult, donor1	10049-101G4	64.90	0.00	0.94	4.70	0.00	0.00	0.00	0.00	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	11.18	0.56	0.00	0.28	0.28	0.00	0.00	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	95.74	15.67	6.47	3.24	16.86	4.43	0.51	1.53	1.70	1.53
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	48.85	4.47	3.48	3.15	2.65	1.16	0.17	0.17	0.33	0.17
paracentral gyrus, adult, pool1	10035-101E8	99.58	2.01	3.20	4.76	3.94	0.09	0.09	0.18	0.00	0.18
parietal cortex, adult, donor10258	10373-105G4	69.73	2.20	0.73	2.20	5.14	0.00	0.00	1.47	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	79.00	0.00	0.94	2.82	0.94	0.00	0.94	0.94	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	104.61	2.28	1.14	3.14	2.57	0.00	0.00	0.86	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	109.71	2.11	1.85	4.85	3.17	0.35	0.00	0.35	0.09	0.44
parietal lobe, fetal, donor1	10072-101I9	80.50	1.94	2.91	4.85	1.94	0.00	0.97	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	47.11	2.24	1.87	4.11	2.24	0.37	0.00	0.00	0.37	0.00
parotid gland, adult	10199-103F1	46.87	1.23	0.62	7.40	1.23	0.62	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	66.60	0.00	2.15	0.54	1.07	0.00	0.00	0.54	0.00	0.54
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	36.07	0.19	0.56	2.79	1.30	0.00	0.00	0.19	0.00	0.19
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	96.01	1.17	1.46	3.35	2.19	0.00	0.00	0.15	0.00	0.15
pineal gland - adult, donor10196	10179-103C8	94.82	0.65	0.00	1.29	1.29	0.00	0.00	0.65	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	88.24	0.00	0.59	0.00	2.37	0.00	0.00	0.00	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	47.66	0.00	2.51	1.25	0.63	0.63	0.00	0.63	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	53.63	1.01	5.06	6.07	2.02	0.00	0.00	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	82.35	0.00	0.52	4.69	1.04	0.52	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	38.31	0.00	3.40	7.66	2.55	0.00	0.85	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	59.23	1.18	1.29	1.18	1.18	0.22	0.00	0.00	0.11	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	59.99	1.06	5.43	12.98	5.69	0.00	1.19	0.66	0.00	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	52.61	3.11	1.87	2.02	4.82	0.31	0.00	0.00	0.00	0.62
pons, adult, pool1	10033-101E6	71.44	1.72	1.72	3.44	2.84	0.09	0.00	0.26	0.00	0.17
postcentral gyrus, adult, pool1	10032-101E5	119.69	2.27	2.35	5.06	3.40	0.09	0.09	0.26	0.17	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	194.50	0.00	2.09	8.37	18.82	2.09	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	49.57	0.00	5.51	5.51	11.02	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	0.00	0.00	0.00	11.74	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	139.25	16.61	7.14	9.61	6.55	4.22	1.02	1.46	0.58	0.44
prostate cancer cell line:PC-3	10439-106E7	169.34	117.79	18.15	20.33	14.16	71.69	5.81	7.80	7.62	0.73
prostate, adult, pool1	10022-101D4	66.30	0.54	1.00	2.90	0.82	0.09	0.09	0.09	0.00	0.00
putamen, adult, donor10196	10176-103C5	128.18	4.01	5.67	5.19	2.83	0.24	0.24	0.94	0.24	1.42
putamen, adult, donor10252	10152-102I8	100.00	0.00	1.96	5.88	3.92	0.00	0.00	0.00	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	52.45	1.09	0.00	1.09	5.46	0.00	0.00	0.00	1.09	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	78.28	3.14	4.59	4.35	0.97	0.00	0.48	0.24	0.00	0.00
putamen, newborn, donor10223	10365-105F5	20.99	0.75	1.50	1.50	2.25	0.00	0.00	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	41.89	3.49	2.62	1.75	4.95	0.00	0.00	0.29	0.00	0.00
rectum, fetal, donor1	10067-101I4	62.59	1.39	0.00	1.39	2.78	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	67.63	3.82	2.76	3.60	4.24	2.54	0.21	1.48	0.42	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	57.58	1.66	2.49	13.25	2.07	0.00	0.41	0.83	0.41	0.00
retina, adult, pool1	10030-101E3	62.62	0.40	0.60	3.08	1.29	0.00	0.20	0.00	0.10	0.20
retinoblastoma cell line:Y79	10475-106I7	82.36	1.04	0.78	2.34	6.50	0.26	0.00	0.26	0.00	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	104.26	4.06	1.11	3.32	4.67	1.23	0.61	0.37	0.12	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	158.60	1.12	0.84	2.53	5.06	0.56	0.00	0.00	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	117.47	7.58	10.61	17.43	4.55	3.03	1.52	1.52	0.76	0.00
salivary acinar cells, donor1	11771-123I7	48.07	1.94	11.49	11.65	2.75	1.13	0.81	0.81	0.16	0.00
salivary acinar cells, donor2	11772-123I8	30.70	0.83	4.96	3.72	1.51	0.28	0.14	0.00	0.00	0.41
salivary acinar cells, donor3	11773-123I9	43.70	0.00	2.65	4.63	0.66	0.66	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	65.77	0.57	2.86	2.29	2.86	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	61.97	5.14	8.85	7.93	7.17	1.69	1.69	0.93	0.42	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	69.59	9.99	9.64	8.70	6.00	1.41	0.59	0.82	0.35	0.12
seminal vesicle, adult	10201-103F3	53.44	0.00	2.12	2.65	3.17	0.00	0.00	0.53	0.00	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	46.40	4.37	2.43	0.97	4.13	0.49	0.49	0.24	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	69.20	2.52	1.01	1.51	0.75	1.01	0.00	0.25	0.00	2.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	127.45	5.02	0.00	3.01	9.03	1.00	0.00	1.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	63.40	1.75	2.01	0.40	4.57	0.40	0.00	0.00	0.13	0.00
signet ring carcinoma cell line:Kato III	10436-106E4	39.68	4.53	4.64	2.43	6.08	0.77	0.00	0.22	0.22	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	33.16	0.77	1.16	0.39	1.03	0.00	0.00	0.00	0.13	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	75.19	0.71	0.00	1.42	0.00	0.71	0.00	0.00	0.00	0.71
skeletal muscle, adult, pool1	10023-101D5	93.43	1.08	0.60	1.56	1.44	0.12	0.00	0.00	0.12	0.24
skeletal muscle, fetal, donor1	10066-101I3	36.18	0.00	0.00	0.00	2.01	0.00	0.00	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	71.33	1.26	0.00	6.31	0.63	0.00	0.00	0.00	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	45.36	1.67	0.67	3.00	1.67	0.00	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	59.89	0.95	0.63	1.26	2.52	0.00	0.00	0.00	0.00	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	166.92	0.96	0.77	16.77	3.08	1.35	0.00	1.16	0.19	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	46.98	0.00	0.16	0.16	2.64	0.00	0.00	0.16	0.16	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	39.57	0.32	0.00	0.16	1.93	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	114.19	1.09	1.53	2.83	3.49	0.44	0.44	0.44	0.00	0.44
small intestine, adult, pool1	10024-101D6	51.72	0.60	0.96	1.07	1.67	0.12	0.00	0.00	0.00	0.24
small intestine, fetal, donor1	10064-101I1	47.91	0.49	1.23	2.46	1.97	0.49	0.00	0.00	0.00	1.23
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	36.42	0.00	1.03	0.51	2.56	1.03	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	63.84	0.26	1.55	2.58	0.78	0.00	0.00	0.00	0.26	0.78
somatostatinoma cell line:QGP-1	10781-110G7	64.33	0.54	0.00	0.00	2.68	0.27	0.00	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	69.51	1.38	1.84	1.84	1.61	0.00	0.00	0.00	0.46	0.23
spinal cord, adult, donor10252	10159-103A6	71.36	0.79	0.79	2.37	0.39	0.00	0.00	0.39	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	36.67	0.00	0.69	0.69	0.00	0.00	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	112.82	1.83	1.83	1.83	1.22	0.00	0.00	0.61	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	47.30	0.46	1.84	2.30	3.67	0.00	0.00	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	164.14	19.27	17.92	9.71	14.34	14.19	2.84	3.14	2.09	0.60
spleen, adult, pool1	10025-101D7	60.24	1.98	1.10	3.41	1.21	0.44	0.33	0.33	0.00	0.33
spleen, fetal, pool1	10044-101F8	65.23	2.07	2.78	5.24	1.75	0.56	0.16	0.16	0.00	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	33.85	0.41	0.72	2.48	3.93	0.10	0.21	0.00	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	51.08	2.47	0.95	1.14	1.14	0.38	0.38	0.19	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	67.09	1.75	0.35	0.70	0.35	0.70	0.00	0.00	0.00	0.35
squamous cell carcinoma cell line:T3M-5	10616-108G4	48.87	35.18	4.30	1.17	8.99	9.38	0.00	1.17	2.74	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	46.49	13.17	1.69	0.34	14.18	1.13	0.11	0.23	0.79	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	42.78	0.85	4.24	2.97	5.93	0.42	0.42	0.42	0.42	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	112.96	32.58	33.00	32.15	11.42	14.38	8.04	2.12	1.27	0.42
stomach, fetal, donor1	10062-101H8	60.87	0.00	1.07	4.27	1.07	0.00	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	38.17	0.00	1.14	7.98	0.57	0.00	0.00	0.00	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	0.00	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	108.84	2.70	0.21	1.66	1.25	0.42	0.00	0.42	0.21	1.45
substantia nigra, adult, donor10258	10371-105G2	55.86	0.00	2.07	1.03	0.52	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	26.14	0.00	1.41	2.12	2.83	0.00	0.00	0.71	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	50.21	0.92	0.92	1.60	4.13	0.00	0.00	0.23	0.23	0.46
temporal lobe, adult, pool1	10031-101E4	126.48	2.63	2.63	6.78	3.98	0.25	0.08	0.93	0.08	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	138.89	1.42	0.71	7.83	5.70	0.00	0.00	0.71	0.00	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	94.50	1.32	1.32	7.91	4.83	0.44	0.44	0.00	0.00	1.32
tenocyte, donor1	11763-123H8	149.42	26.18	19.90	14.66	9.43	11.52	2.79	3.84	1.05	2.09
tenocyte, donor2	11765-123I1	70.20	12.59	14.12	11.45	4.58	2.29	0.76	0.38	0.00	0.38
tenocyte, donor3	11768-123I4	140.85	29.65	21.13	17.79	9.64	21.50	4.45	4.82	2.97	3.71
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	48.61	0.68	1.87	0.68	3.74	0.17	0.00	0.34	0.00	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	53.18	0.15	0.92	1.23	4.16	0.00	0.00	0.15	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	57.19	0.77	2.48	0.93	5.27	0.15	0.00	0.00	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	59.28	1.40	6.98	2.41	5.84	0.89	0.25	0.51	0.25	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	72.23	0.00	5.29	1.89	10.21	0.00	0.00	0.00	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	60.97	2.94	13.20	2.51	4.36	0.11	0.00	0.00	0.11	0.22
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	63.84	0.98	3.58	1.95	3.58	0.00	0.00	0.33	0.33	0.00
testis, adult, pool1	10026-101D8	77.31	11.60	8.05	6.44	3.11	0.54	1.18	0.54	0.43	0.21
testis, adult, pool2	10096-102C6	109.61	14.89	14.43	12.63	4.51	1.80	0.90	2.26	0.90	2.26
thalamus - adult, donor10196	10168-103B6	91.63	1.10	2.21	0.00	4.42	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	107.21	2.19	1.25	1.88	1.88	0.00	0.00	0.16	0.31	0.16
thalamus, adult, donor10258, tech_rep1	10370-105G1	24.63	0.00	0.00	1.54	1.54	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	34.58	0.66	0.66	0.99	1.65	0.00	0.16	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	33.37	0.58	2.30	0.00	2.88	0.00	0.58	1.15	0.00	0.00
throat, adult	10209-103G2	52.68	1.25	1.00	2.50	1.00	0.25	0.00	0.25	0.00	0.25
throat, fetal, donor1	10061-101H7	71.61	0.30	2.44	3.66	3.05	0.30	0.61	0.00	0.00	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	56.84	1.79	0.79	6.96	8.55	0.20	0.00	0.40	0.00	0.40
thymus, adult, pool1	10027-101D9	85.10	6.66	6.56	9.74	5.37	0.10	0.80	0.30	0.10	0.60
thymus, fetal, pool1	10043-101F7	72.01	4.26	5.09	9.46	2.49	0.31	0.21	0.31	0.42	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	59.97	25.26	7.31	5.58	9.84	13.16	1.06	0.93	2.53	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	172.94	27.80	21.65	16.06	20.53	9.78	3.77	3.21	2.65	0.70
thyroid, adult, pool1	10028-101E1	114.40	1.68	5.13	4.48	2.33	0.37	0.00	0.00	0.09	0.19
thyroid, fetal, donor1	10060-101H6	79.89	0.79	3.95	2.64	2.64	0.26	0.00	0.26	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	104.71	3.08	3.08	3.08	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	70.70	10.93	2.56	2.79	2.56	12.33	0.47	0.23	0.93	1.40
tongue, fetal, donor1	10059-101H5	75.27	0.39	1.58	1.58	0.79	0.39	0.00	0.79	0.00	0.00
tonsil, adult, pool1	10047-101G2	70.72	4.11	2.60	5.21	2.50	1.50	0.20	0.30	0.40	0.20
trachea, adult, pool1	10029-101E2	54.48	1.55	1.23	2.13	1.06	0.49	0.08	0.08	0.33	0.33
trachea, fetal, donor1	10058-101H4	53.09	0.00	2.31	2.69	1.92	0.00	0.00	0.38	0.00	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	159.07	36.49	43.58	18.07	13.82	24.45	7.79	6.02	2.48	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	59.17	7.80	3.95	2.94	11.45	2.13	0.61	0.30	0.81	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	59.54	18.80	30.71	20.68	12.38	4.39	4.23	5.64	0.63	0.63
tridermal teratoma cell line:HGRT	10694-109G1	256.84	36.15	7.61	32.34	15.22	49.47	5.71	3.81	7.61	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	166.76	18.96	61.12	26.33	9.90	6.35	4.83	2.54	1.69	0.42
umbilical cord, fetal, donor1	10057-101H3	64.68	0.00	4.17	0.00	2.09	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	73.37	0.68	2.22	3.24	1.37	0.51	0.00	0.17	0.00	0.00
uterus, fetal, donor1	10055-101H1	69.11	0.51	0.51	2.56	1.02	2.05	0.00	0.00	0.00	0.00
vagina, adult	10204-103F6	48.46	1.94	0.65	1.29	1.29	0.00	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	53.48	1.32	4.16	7.45	2.63	0.22	0.22	0.00	0.00	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	59.82	2.94	8.28	21.63	2.40	0.27	1.07	0.53	0.53	0.00